|
|
Drugs for Gastrointestinal Lymphoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 395)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Gemcitabine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1881 | 95058-81-4 | 60750 | 103882-84-4 122111-03-9 2',2'-DiF-dC 2',2'-Difluoro-2'-deoxycytidine 2',2'-Difluorodeoxycytidine 2'-Deoxy-.beta.-D-2',2'-difluorocytidine 2'-Deoxy-2',2'-difluorocytidine 4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one 4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one 4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one 4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one 95058-81-4 AB1004842 AC1L1TUQ C07650 CCRIS 8984 CHEBI:175901 CHEMBL888 CID60750 Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine D02368 DB00441 DDFC DFDC DFdC DFdCyd Folfugem GEO Gamcitabine GemLip Gemcel | Gemcin Gemcitabin Gemcitabina Gemcitabina [INN-Spanish] Gemcitabine Gemcitabine (USAN/INN) Gemcitabine HCl Gemcitabine Hydrochloride Gemcitabine hydrochloride Gemcitabine stereoisomer Gemcitabinum Gemcitabinum [INN-Latin] Gemtro Gemzar Gemzar (hydrochloride) HMS2089P10 HSDB 7567 Inno-D07001 LS-59139 LY 188011 LY-188011 LY188011 NCGC00168784-01 NChemBio.2007.10-comp25 NSC 613327 NSC613327 TL8005979 UNII-B76N6SBZ8R ZINC18279854 Zefei gemcitabine nchembio.573-comp7 nchembio.90-comp2 |
| | 2 | | Ifosfamide | approved | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 371 | 3778-73-2 | 3690 | (+-)-Ifosfamid (+-)-Ifosphamide (+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide (D,L)-Ifosfamide (R,S)-Ifosphamide (R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide 1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide 1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide 2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd 2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide 2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI) 2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide 3,} 2-oxazaphosphorine oxide 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide 3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide 3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide 36341-88-5 3778-73-2 84711-20-6 A 4942 AB00513932 AC-2113 AC1L1GHW ASTA Z 4942 Ambap3778-73-2 Asta Z 4942 BPBio1_000865 BRN 0611835 BSPBio_000785 C07047 CAS-3778-73-2 CCRIS 352 CHEBI:5864 CHEMBL1024 CID3690 Cyfos D00343 D007069 DB01181 EINECS 223-237-3 HMS1570H07 HMS2090M12 HMS2093N07 HSDB 7023 Holoxan Holoxan 1000 I-Phosphamide I06-0494 IFEX (TN) Ifex Ifosfamid Ifosfamida Ifosfamida [INN-Spanish] Ifosfamide | Ifosfamide (JAN/USP/INN) Ifosfamide Sterile Ifosfamide [USAN:INN:BAN:JAN] Ifosfamidum Ifosfamidum [INN-Latin] Ifosphamide Ifsofamide Iphosphamid Iphosphamid(e) Iphosphamide Iso Endoxan Iso-Endoxan Isoendoxan Isofosfamide Isophosphamide Isosfamide LS-102 LS-99799 MJF 9325 MJF-9325 MLS002154021 Mitoxana Mitoxana, Ifex, Ifosfamide MolPort-003-666-704 N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German] N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine NCGC00016639-01 NCGC00179435-01 NCI-C01638 NCI60_000233 NPFAPI-04 NSC 109,724 NSC 109724 NSC-109,724 NSC-109724 NSC109,724 NSC109724 Naxamide Prestwick0_000833 Prestwick1_000833 Prestwick2_000833 Prestwick3_000833 S1302_Selleck SMR001233348 SPBio_002706 STL058690 UNII-UM20QQM95Y WLN: T6NPOTJ AM2G BO B2G Z 4942 Z-4942 Z4942 ifosfamide isosfamide {3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1, |
| | 3 | | Oxaliplatin | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 1322 | 61825-94-3 | 5310940, 9887054, 6857599, 43805, 6857599, 9887054 | CHEMBL1201055 CID9887054 D01790 DACPLAT Diaminocyclohexane Oxalatoplatinum Eloxatin Eloxatin (TN) Elplat Foloxatine L-OHP | Oxalatoplatin Oxalatoplatinum Oxaliplatin Oxaliplatin (JAN/USAN/INN) Oxaliplatin [Usan:Inn:Ban] Oxaliplatino [Spanish] Oxaliplatinum [Latin] Oxaloplatine [French] Oxaloplatino [Spanish] Transplatin oxaliplatin | |
| | 4 | | Dexamethasone | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 1909 | 50-02-2 | 5743 | (3H)-Dexamethasone .delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol .gamma.corten 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone 1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone 1-Dehydro-16α-methyl-9α-fluorohydrocortisone 137098-19-2 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone 16-alpha-Methyl-9-alpha-fluoroprednisolone 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol 16.alpha.-Methyl-9.alpha.-fluoroprednisolone 16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol 16alpha -Methyl-9alpha -fluoroprednisolone 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone 16alpha-Methyl-9alpha-fluoroprednisolone 16α-Methyl-9α-fluoro-1-dehydrocortisol 23495-06-9 31375_FLUKA 46165_FLUKA 46165_RIEDEL 50-02-2 8054-59-9 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione 9-Fluoro-16-methylprednisolone 9-alpha-Fluoro-16-alpha-methylprednisolone 9.alpha.-Fluoro-16.alpha.-methylprednisolone 906422-84-2 9A-FLUORO-16BETA-METHYLPREDNISOLONE 9alpha -Fluoro-16alpha -methylprednisolone 9alpha-Fluoro-16alpha-methylprednisolone 9alpha-fluoro-16alpha-methyl-Prednisolone 9α-Fluoro-16α-methylprednisolone AC-11056 AC1L1L1H AC1Q29DM AI3-50934 Adexone Aeroseb-D Aeroseb-Dex Aeroseb-dex Ak Dex Oph Otic Soln 0.1% Alcon Brand of Dexamethasone Anaflogistico Aphtasolon Aphthasolone Apo-dexamethasone Auxiron Azimycin (veterinary) Azium Azium (Veterinary) Azium (veterinary) BIDD:ER0494 BIDD:PXR0060 BRD-K38775274-001-02-3 BRD-K38775274-001-06-4 BSPBio_000995 Baycadron Bisu DS Bisu Ds C15643 C22H29FO5 CCRIS 7067 CHEBI:41879 CHEMBL384467 CID5743 CPD-10549 CPD001227192 Calonat Corson Corsone Cortisumman D00292 D003907 D1756_SIGMA D4902_SIGMA D6645_SIGMA D8893_SIGMA D9184_SIGMA DB01234 DEX DEXA DEXONE 0.5 DEXONE 0.75 DEXONE 1.5 DEXONE 4 DXM DXMS Decacort Decacortin Decaderm Decadron Decadron (TN) Decadron Tablets, Elixir Decadron, Dexamethasone Decadron-LA Decadron-La Decagel Decaject Decaject L.A. Decaject-L.A. Decalix Decameth Decasone Decaspray Dectancyl Dekacort Delta1-9alpha-Fluoro-16alpha-methylcortisol Deltafluorene Dergramin Deronil Desadrene Desametasone Desametasone [DCIT] Desametasone [Dcit] Desamethasone Desameton Deseronil Dex-Ide Dex-ide Dexa Dexa Mamallet Dexa mamallet Dexa-Cortidelt Dexa-Cortisyl Dexa-Mamallet Dexa-Scheroson Dexa-Sine Dexa-cortidelt Dexa-cortisyl Dexa-scheroson Dexa-sine Dexacen-4 Dexacidin Dexacort Dexacortal Dexacortin Dexadeltone Dexafarma Dexair Dexalona Dexaltin Dexametasona Dexametasona [INN-Spanish] Dexametasone Dexameth Dexamethansone | Dexamethasone Dexamethasone (JP15/USP/INN) Dexamethasone Acetate Dexamethasone Alcohol Dexamethasone Base Dexamethasone Intensol Dexamethasone Sodium Phosphate Dexamethasone [INN:BAN:JAN] Dexamethasone acetate Dexamethasone alcohol Dexamethasone base Dexamethasone intensol Dexamethasone sodium phosphate Dexamethasone-omega Dexamethasonum Dexamethasonum [INN-Latin] Dexamethazone Dexamethsone Dexamonozon Dexapolcort Dexapos Dexaprol Dexason Dexasone Dexasone 0.5mg Dexasone 0.75mg Dexasone 4mg Dexasporin Dexinolon Dexinoral Dexone Dexone 0.5 Dexone 0.75 Dexone 1.5 Dexone 4 Dexonium Dexpak Dextelan Dezone Dinormon Dxms ECR Brand of Dexamethasone EINECS 200-003-9 FT-0080377 Fluormethylprednisolone Fluormone Fluorocort Fortecortin Foy Brand of Dexamethasone Gammacorten HL-dex HMS1792A17 HMS1990A17 HMS2089N13 HSDB 3053 Hexadecadrol Hexadrol Hexadrol Elixir Hexadrol Tablets Hexadrol elixir Hl-Dex Hl-dex I06-1196 ICN Brand of Dexamethasone IontoDex Isopto-Dex Isopto-dex LS-7300 Lokalison F Lokalison f Loverine Luxazone MK 125 MLS001055412 MLS001332507 MLS001332508 Maxidex Maxidex Ont 0.1% Maxidex Sus 0.1% Maxitrol Mediamethasone Merck Brand of Dexamethasone Merz Brand 1 of Dexamethasone Merz Brand 2 of Dexamethasone Methylfluorprednisolone Mexidex Millicorten MolMap_000018 MolPort-003-846-433 Mymethasone NCGC00091019-01 NCGC00091019-02 NCGC00091019-03 NCGC00091019-04 NCGC00091019-05 NCI60_003067 NSC 34521 NSC34521 Naquasone (veterinary) Neomycin and polymyxin b sulfates and dexamethasone Neomycin and polymyxin b sulphates and dexamethasone OTO-104 Ocu-Trol Ocu-trol Oradexon Ozurdex PHL-dexamethasone PMS-dexamethasone Pet Derm III Pet Derm Iii Pet derm III Pet-Derm Iii Pms Dexamethasone Elixir 0.5mg/5ml Policort Posurdex Prednisolon F Prednisolon f Prednisolone F Prednisolone f Prodex S1322_Selleck SAM002548948 SGCUT00126 SK-Dexamethasone SK-dexamethasone SMP1_000092 SMR000857119 SMR001227192 ST50307091 Sandoz dexamethasone Sk-Dexamethasone Spectrum5_002019 Spoloven Sunia Sol D Sunia sol D Superprednol TL8003317 Tobradex Tobramycin and dexamethasone Tresaderm (veterinary) Turbinaire UNII-7S5I7G3JQL Visumetazone WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1 ZINC03875332 alpha -Fluoro-16-alpha -methylcortisol delta(Sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol delta1-9alpha-Fluoro-16alpha-methylcortisol dexamethasone nchembio809-comp2 to_000038 | |
| | 5 | | rituximab | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1582 | 174722-31-7 | 10201696 | AntiCD20 IDEC-102 IDEC-C2B8 | Ig gamma-1 chain C region MabThera Mabthera Rituxan rituximab |
| | 6 | | Thioguanine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 77 | 154-42-7 | 2723601 | 154-42-7 2 Amino 6 Purinethiol 2-Amino 6MP 2-Amino 6mp 2-Amino-1,7-dihydro-6H-purin-6-thion 2-Amino-1,7-dihydro-6H-purin-6-thion [Czech] 2-Amino-1,7-dihydro-6H-purine-6-thione 2-Amino-6-MP 2-Amino-6-mercaptopurine 2-Amino-6-merkaptopurin 2-Amino-6-merkaptopurin [Czech] 2-Amino-6-purinethiol 2-Amino-9H-purine-6-thiol 2-Aminopurin-6-thiol 2-Aminopurin-6-thiol [Czech] 2-Aminopurine-6(1H)-thione 2-Aminopurine-6-thiol 2-Thioguanine 2-amino-1,9-Dihydropurine-6-thione 2-amino-1H-purine-6(7H)-thione 2-amino-3,7-dihydropurine-6-thione 2-aminopurine-6-thiol 5580-03-0 6 Thioguanine 6-Mercapto-2-aminopurine 6-Mercaptoguanine 6-TG 6-Thioguanine 6-Thioguanine (6-TG) 6-Thioguanine, Thioguanine A4660_SIGMA A4882_SIGMA AC-11125 AC1MC379 AI3-26078 AKOS003389499 BSPBio_001994 BW 5071 C07648 C5H7N5S CCRIS 8997 CHEBI:136864 CHEMBL727 CID2723601 D013866 D08603 DB00352 DX4 DivK1c_000428 EINECS 205-827-2 FT-0083572 Glaxo Wellcome Brand of Thioguanine Glaxo Wellcome Brand of Tioguanine GlaxoSmithKline Brand of Thioguanine GlaxoSmithKline Brand of Tioguanine Guanine, thio- (VAN) HMS1921E09 HMS2092M11 HMS501F10 HSDB 2504 I14-1541 IDI1_000428 KBio1_000428 KBio2_000715 KBio2_002476 KBio2_003283 KBio2_005044 | KBio2_005851 KBio2_007612 KBio3_001494 KBio3_002954 KBioGR_001452 KBioGR_002476 KBioSS_000715 KBioSS_002483 LS-888 LT00455187 Lanvis Lanvis (TN) MLS001333131 MLS001333132 MolPort-000-929-106 MolPort-001-813-204 MolPort-003-984-174 NCGC00094792-01 NCGC00094792-02 NCGC00094792-03 NCI60_041643 NCIOpen2_004153 NINDS_000428 NSC 752 NSC-752 NSC752 S1774_Selleck SBB067147 SMP2_000326 SMR000857244 SPBio_000849 SPECTRUM1500573 ST50298831 Spectrum2_000695 Spectrum3_000577 Spectrum4_000926 Spectrum5_001455 Spectrum_000235 T0212 TG THG Tabloid ThG Thioguanin GSK Thioguanin-GSK ThioguaninGSK Thioguanine Thioguanine Hemihydrate Thioguanine Monosodium Salt Thioguanine Tabloid Thioguanine [USAN:BAN] Tioguanin Tioguanina Tioguanina Wellcome Tioguanina [INN-Spanish] Tioguanine Tioguanine (INN) Tioguanine GlaxoSmithKline Brand Tioguaninum Tioguaninum [INN-Latin] UNII-FTK8U1GZNX UNII-WIX31ZPX66 WLN: T56 BNM FYM INJ FUS HZ Wellcome Brand of Thioguanine Wellcome U3B ZINC18085533 cMAP_000061 purine antimetabolite: antimetabolite: inhibits nucleic acid replication thioguanine |
| | 7 | | Asparaginase | approved | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 201 | 9015-68-3 | | | Kidrolase L-asparagine amidohydrolase Putative L-asparaginase precursor | |
| | 8 | | Vinblastine | approved | Phase 4, Phase 3, Phase 2 | 230 | 865-21-4 | 13342, 241903 | (2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE (2alpha,2'BETA,3beta,4alpha,5beta)-vincaleukoblastine (2xi,3beta,4'beta,19xi)-vincaleukoblastine (3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-methyl 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-1H-indolizino(8,1-cd)carbazole-5-carboxylate 143-67-9 1z2b 29060-LE 865-21-4 AC-20335 AC1L21JC AC1L68D2 AC1MXZJ2 BIDD:PXR0201 BRD-K01188359-065-02-5 BSPBio_001228 BSPBio_003594 Bio-0111 C07201 C46H58N4O9 CCRIS 9002 CHEBI:171516 CHEBI:27375 CHEMBL159 CHEMBL607706 CID13342 CID241903 CID3823887 CID6710780 D08675 DB00570 EINECS 212-734-0 HMS2090K05 HSDB 3263 KBio3_003033 LS-1859 LS-187263 | MolPort-002-518-262 MolPort-005-910-359 NCGC00022585-04 NCGC00181127-01 NCI-C04842 NCI60_004200 NChemBio.2007.10-comp22 NDC 0002-1452-01 NSC 47842 Neuro_000020 Nincaluicolflastine Rozevin SPBio_000680 STOCK1N-38480 Spectrum2_000890 Spectrum3_001994 UNII-5V9KLZ54CY VLB VR-8 Velban Velbe Vinblastin Vinblastina Vinblastina (TN) Vinblastina [DCIT] Vinblastina [Dcit] Vinblastine Vinblastine (INN) Vinblastine Sulfate Vinblastine [INN:BAN] Vinblastinum Vinblastinum [INN-Latin] Vincaleucoblastin Vincaleucoblastine Vincaleukoblastine Vincoblastine nchembio873-comp22 vinblastine |
| | 9 | | Prednisone | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1267 | 53-03-2 | 5865 | (1S,2R,10S,11S,14R,15S)-14-hydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,17-dione (8S,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,11-dione (8xi,9xi,14xi)-17,21-dihydroxypregna-1,4-diene-3,11,20-trione .delta. E .delta.(sup1)-Cortisone .delta.-Cortelan .delta.-Cortisone .delta.-Cortone .delta.-E .delta.1-Cortisone .delta.1-Dehydrocortisone .delta.sone 1,2-Dehydrocortisone 1,4-Pregnadiene-17-alpha,21-diol-3,11,20-trione 1,4-Pregnadiene-17.alpha.,21-diol-3,11,20-trione 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione 1-Cortisone 1-Dehydrocortisone 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione 17alpha,21-Dihydroxy-1,4-pregnadiene-3,11,20-trione 53-03-2 68-59-7 81552_FLUKA AC-11112 AC1L1LB2 AC1Q29EZ ACon0_000082 ACon1_000297 AI3-52939 Adasone Ancortone Apo-Prednisone Apo-prednisone BPBio1_000323 BRD-K85883481-001-04-2 BSPBio_000293 Betapar Bicortone Bio-0649 C07370 C21H26O5 CCRIS 2646 CHEBI:8382 CHEMBL635 CID5865 CPD001227202 Cartancyl Colisone Cortan Cortancyl Cortidelt Cotone DB00635 Dacorten Dacortin Decortancyl Decortin Decortisyl Dehydrocortisone Dekortin Delcortin Dellacort Dellacort A Delta Cortelan Delta E Delta E. Delta-Cortelan Delta-Dome Delta-cortelan Delta-cortisone Delta-cortone Delta-dome Deltacortene Deltacortisone Deltacortone Deltasone Deltasone, Liquid Pred, Orasone, Adasone, Deltacortisone,Prednisone Deltison Deltisona Deltisone Deltra Di-Adreson Diadreson EINECS 200-160-3 Econosone Encorton Encortone Enkortolon Enkorton Fernisone Fiasone HMS1568O15 HMS2090J13 HSDB 3168 Hostacortin In-Sone Incocortyl Juvason | Kortancyl LMST02030180 LS-1325 Liquid Pred Lisacort Lodotra MEGxm0_000443 MLS001061265 MLS001304073 MLS001335907 MLS001335908 MLS002154191 MLS002207083 Me-Korti Metacortandracin Meticorten Meticorten (Veterinary) Metrevet (Veterinary) MolPort-001-740-041 NCGC00090766-01 NCGC00090766-02 NCGC00090766-03 NCI-C04897 NCI60_000008 NSC 10023 NSC10023 Nisona Nizon Novoprednisone Nurison Orasone Origen Prednisone P1276 P6254_SIGMA PRD Panafcort Panasol Paracort Parmenison Pehacort Perrigo Prednisone Precort Predeltin Prednicen-M Prednicorm Prednicort Prednicot Prednidib Prednilonga Prednison Prednisona Prednisona [INN-Spanish] Prednisone Prednisone Intensol Prednisone [INN:BAN] Prednisonum Prednisonum [INN-Latin] Prednitone Prednizon Prednovister Presone Prestwick0_000077 Prestwick1_000077 Prestwick2_000077 Prestwick3_000077 Prestwick_405 Pronison Pronisone Rayos Rectodelt Retrocortine S1622_Selleck SAM002264641 SK-Prednisone SMR000718760 SMR001227202 SPBio_002214 Servisone Sone Sterapred Supercortil U 6020 UNII-VB0R961HZT Ultracorten Ultracortene WLN: L E5 B666 CV OV AHTTT&J A1 E1 FV1Q FQ Winpred Wojtab ZINC03875357 Zenadrid Zenadrid (veterinary) Zenadrid [veterinary] delta cortelan delta(sup 1)-Cortisone delta(sup 1)-Dehydrocortisone delta-1-Cortisone delta-1-Dehydrocortisone delta-Cortisone delta-Cortone | |
| | 10 | | Vincristine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 863 | 2068-78-2, 57-22-7 | 5978 | 22-Oxovincaleukoblastin 22-Oxovincaleukoblastine 28379-27-3 57-22-7 AC1L1LJC C07204 C46H56N4O10 CCRIS 5763 CHEBI:28445 CID5978 D08679 DB00541 EINECS 200-318-1 HMS2090E19 HSDB 3199 Indole alkaloid LCR LS-228 Leurocristine Lilly 37231 (1:1 sulfate salt) Liposomal Vincristine Marqibo NCGC00163700-01 NCI-C04864 NCI60_026703 NSC-67574 Onco TCS | Oncovin Oncovin (1:1 sulfate salt) Oncovine Tecnocris Tecnocris (TN) UNII-5J49Q6B70F VCR VIN Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine Vincasar Vincasar (1:1 sulfate salt) Vincasar PFS Vincrex Vincrex (1:1 sulfate salt) Vincristin Vincristina Vincristina [DCIT] Vincristine (INN) Vincristine Sulfate Vincristine Sulfate PFS Vincristine [INN:BAN] Vincristinum Vincristinum [INN-Latin] Vincrstine Vincrystine Vinkristin Z-D-Val-Lys(Z)-OH vincristine | |
| | 11 | | Pegaspargase | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 119 | 130167-69-0 | | L-asparagine amidohydrolase | Oncaspar Putative L-asparaginase precursor | |
| | 12 | | Methotrexate | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1444 | 1959-05-2, 59-05-2 | 126941 | 4-amino-10-methylfolic acid 4-amino-N(10)-Methylpteroylglutamic acid Abitrexate Amethopterin Amethopterine Antifolan Arbitrexate Emtexate Folex HDMTX L-Amethopterin Ledertrexate MTX Metatrexan Methopterin Methotextrate | Methotrate Methotrexat Methotrexate Methotrexate Sodium Methotrexatum Methylaminopterin Methylaminopterinum Metoject Metotrexato Mexate Méthotrexate N-Bismethylpteroylglutamic Acid N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid Otrexup Rasuvo Rheumatrex Rheumatrex Dose Pack Trexall |
| | 13 | | Cyclophosphamide | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 2643 | 50-18-0, 6055-19-2 | 2907 | (+-)-Cyclophosphamide (-)-Cyclophosphamide (RS)-Cyclophosphamide 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin 2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide 4-Hydroxy-cyclophosphan-mamophosphatide 50-18-0 60007-95-6 6055-19-2 (monohydrate) 75526-90-8 AC1L1EQQ AI3-26198 ASTA ASTA B518 Asta B 518 B 518 B-518 BRN 0011744 BSPBio_002099 Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester C 0768 C07888 C7H15Cl2N2O2P CB 4564 CB-4564 CCRIS 188 CHEBI:4027 CHEMBL32520 CHEMBL88 CID2907 CP CPA CTX CY Ciclofosfamida Ciclofosfamida [INN-Spanish] Ciclofosfamide Ciclophosphamide Ciclophosphamide [INN] Clafen Claphene Cycloblastin Cyclophosphamid Cyclophosphamide Cyclophosphamide (INN) Cyclophosphamide (TN) Cyclophosphamide (anhydrous form) Cyclophosphamide (anhydrous) Cyclophosphamide Monohydrate Cyclophosphamide Sterile Cyclophosphamide anhydrous Cyclophosphamide, (+-)-Isomer Cyclophosphamides Cyclophosphamidum Cyclophosphamidum [INN-Latin] Cyclophosphan Cyclophosphane Cyclophosphanum Cyclophosphoramide Cyclostin Cyklofosfamid Cyklofosfamid [Czech] Cytophosphan Cytophosphane Cytoxan Cytoxan (TN) Cytoxan Lyoph D,L-Cyclophosphamide D07760 DB00531 | DivK1c_000246 EINECS 200-015-4 EU-0100238 Endoxan Endoxan R Endoxan-Asta Endoxana Endoxanal Endoxane Enduxan Genoxal HMS2090A12 HSDB 3047 Hexadrin IDI1_000246 KBio1_000246 KBio2_001338 KBio2_003906 KBio2_006474 KBio3_001319 KBioGR_000888 KBioSS_001338 LS-1302 LS-99787 Ledoxina Lopac-C-0768 Lopac0_000238 Lyophilized Cytoxan Mitoxan MolPort-001-783-420 N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide NCGC00015209-01 NCGC00015209-03 NCGC00015209-06 NCGC00091741-02 NCGC00091741-03 NCI-C04900 NCI60_002097 NINDS_000246 NSC 26271 NSC-26271 NSC26271 NSC273033 NSC273034 Neosar Occupation, cyclophosphamide exposure Procytox RCRA waste no. U058 Rcra Waste Number U058 Rcra waste number U058 Revimmune S1217_Selleck SK 20501 SPBio_001071 STK177249 STOCK2S-91217 Semdoxan Sendoxan Senduxan Spectrum2_001146 Spectrum3_000370 Spectrum4_000304 Spectrum5_000795 Spectrum_000858 UNII-6UXW23996M WLN: T6MPOTJ BO BN2G2G Zyklophosphamid Zyklophosphamid [German] bis(2-Chloroethyl)phosphami de cyclic propanolamide bis(2-Chloroethyl)phosphamide cyclic propanolamide ester cyclophosphamide | |
| | 14 | | Prednisolone | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1082 | 50-24-8 | 5755 | (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione .DELTA.1-Cortisol .DELTA.1-Dehydrocortisol .DELTA.1-Dehydrohydrocortisone .DELTA.1-Hydrocortisone .delta.-Cortef .delta.-Stab 1,2-Dehydrohydrocortisone 1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione 1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol 1-Dehydrocortisol 1-Dehydrohydrocortisone 3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene 46656_FLUKA 46656_RIEDEL 50-24-8 58201-11-9 8056-11-9 AC-1773 AC1L1L2E Ak-Pred Ak-Tate Alphadrol Articulose-50 BPBio1_000164 BRD-K98039984-001-03-0 BRN 1354103 BSPBio_000148 Bio-0666 Bubbli-Pred C07369 CCRIS 980 CHEBI:8378 CHEMBL131 CID5755 CO-Hydeltra CPD000718761 Co-Hydeltra Codelcortone Cordrol Cortalone Cotogesic Cotolone D00472 D011239 DB00860 Decaprednil Decortin H Delcortol Delta F Delta(1)-dehydrohydrocortisone Delta-Cortef Delta-Cortef (TN) Delta-Ef-Cortelan Delta-Stab Delta-stab Deltacortenol Deltacortril Deltacortril Enteric Deltahydrocortisone Deltasolone Deltisilone Depo-Medrol Derpo PD Derpo Pd Dexa-Cortidelt Hostacortin H Dexa-Cortidelt hostacortin H Di Adreson F Di-Adreson F Di-Adreson-F Di-adreson F DiAdresonF Dicortol Donisolone Dydeltrone EINECS 200-021-7 Eazolin D Econopred Econopred Plus Erbacort Erbasona Estilsona Fernisolone Fernisolone P Fernisolone-P Flamasone Flo-pred HMS1568H10 HMS2090J05 HSDB 3385 Hostacortin H Hydeltra Hydeltra-Tba Hydeltrasol Hydeltrone Hydrodeltalone Hydrodeltisone Hydroretrocortin Hydroretrocortine I-Pred Inflamase Forte Inflamase Mild K 1557 Key-Pred Klismacort LMST02030179 LS-7669 Lentosone Lite Pred M-Predrol MLS001304083 | MLS002154250 MLS002207037 Medrol Medrol Acetate Metacortandralone Methylprednisolone Acetate Meti-Derm Meticortelone Metreton Millipred MolPort-002-507-147 NCGC00179649-01 NSC 9120 NSC9120 NSC9900 Neo-Delta-Cortef Nisolone Nor-Pred T.B.A. Ocu-Pred Ocu-Pred Forte Omnipred Ophtho-Tate Orapred P0152_SIGMA P0637 P6004_SIGMA PRDL PRED-G Panafcortelone Paracortol Paracotol Pediapred Poly-Pred Precortalon Precortancyl Precortilon Precortisyl Pred Forte Pred Mild Predair Predair A Predair Forte Predalone 50 Predalone T.B.A. Predate Predate Tba Predate-50 Predcor-25 Predcor-50 Predcor-Tba Predisolone Sodium Phosphate Predne-Dome Prednelan Predni-Dome Prednicen Predniliderm Predniretard Prednis Prednisolona Prednisolona [INN-Spanish] Prednisolone Prednisolone (JP15/USP/INN) Prednisolone (anhydrous) Prednisolone Acetate Prednisolone Sodium Phosphate Prednisolone Tebutate Prednisolone [INN:BAN:JAN] Prednisolonum Prednisolonum [INN-Latin] Predonin Predonine Prelone Prenolone Prestwick0_000274 Prestwick1_000274 Prestwick2_000274 Prestwick3_000274 Prestwick_404 Rolisone S1737_Selleck SAM002264639 SMR000718761 SPBio_002367 Scherisolon Solone Steran Sterane Sterolone Supercortisol UNII-9PHQ9Y1OLM Ulacort Ultra Pred Ultracorten H Ultracortene H Ultracortene-H Ultracortene-Hydrogen Ultracortene-hydrogen ZINC03833821 component of Ataraxoid component of K-Predne-Dome delta(1)-Cortisol delta(1)-Dehydrocortisol delta(1)-Dehydrohydrocortisone delta(1)-Hydrocortisone delta(sup 1)-Cortisol delta(sup 1)-Dehydrocortisol delta(sup 1)-Dehydrohydrocortisone delta(sup 1)-Hydrocortisone delta-dehydrocortisol delta-dehydrohydrocortisone delta-hydrocortisone prednisolone | |
| | 15 | | Methylprednisolone | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1082 | 83-43-2 | 6741 | (6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one (6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione (6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione .DELTA.1-6.alpha.-Methylhydrocortisone 1-Dehydro-6alpha-methylhydrocortisone 1-dehydro-6alpha-Methylhydrocortisone 1-dehydro-6α-methylhydrocortisone 11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione 11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 121673-01-6 4-08-00-03498 (Beilstein Handbook Reference) 46436_FLUKA 46436_RIEDEL 570-35-4 6 Methylprednisolone 6-Methylprednisolone 6-alpha-Methylprednisolone 6.alpha.-Methylprednisolone 6923-42-8 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 6alpha-Methylprednisolone 6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione 83-43-2 A-methapred AC1L1N7A Artisone-Wyeth Artisone-wyeth BPBio1_000174 BRD-K35240538-001-03-1 BRN 2340300 BSPBio_000158 Besonia Bio-0658 CHEBI:6888 CHEMBL650 CID6741 CPD000058330 D00407 D008775 DB00959 Depo-Medrol (acetate) Depo-medrol Dopomedrol EINECS 201-476-4 Esametone Firmacort HMS1568H20 HMS2090B13 HSDB 3127 LMST02030178 LS-118498 Lemod M0639_SIGMA M1665 MEPRDL MLS000028541 MLS001148159 MLS002207191 Medesone Medixon Medlone 21 | Medrate Medrol Medrol (TN) Medrol Adt Pak Medrol Dosepak Medrol adt pak Medrol dosepak Medrol, Solu-Medrol, Medrone, Methylprednisolone Medrone Mesopren Metastab Methyleneprednisolone Methylprednisolon Methylprednisolone Methylprednisolone (JP15/USP/INN) Methylprednisolone [USAN:INN:BAN:JAN] Methylprednisolone, 6-alpha Methylprednisolonum Methylprednisolonum [INN-Latin] Metilbetasone Metilprednisolona Metilprednisolona [INN-Spanish] Metilprednisolone Metilprednisolone [DCIT] Metilprednisolone [Dcit] Metipred Metrisone Metrocort Metysolon Moderin MolPort-002-528-554 NCGC00022735-03 NCI60_001657 NSC-19987 NSC19987 Nirypan Noretona Predni N Tablinen Prednol- L Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI) Prestwick0_000279 Prestwick1_000279 Prestwick2_000279 Prestwick3_000279 Prestwick_622 Promacortine Reactenol S1733_Selleck SAM002589984 SMR000058330 SPBio_002377 Sieropresol Solomet Solu-medrol Summicort Suprametil U 7532 UNII-X4W7ZR7023 Urbason Urbasone Wyacort ZINC03875560 delta(1)-6alpha-Methylhydrocortisone delta(sup 1)-6-alpha-Methylhydrocortisone methylprednisolone methylprenisolone | |
| | 16 | | Cytarabine | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 1035 | 147-94-4 | 6253 | (beta-D-Arabinofuranosyl)cytosine (beta-D-arabinofuranosyl)cytosine 1-.beta.-D-arabinofuranosyl-cytosine 1-Arabinofuranosylcytosine 1-beta -D-Arabinofaranosylcytosine 1-beta -D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone 1-beta -D-Arabinofuranosylcytosine 1-beta-D-Arabinofaranosylcytosine 1-beta-D-Arabinofuranosyl-4-amino-2(1H)pyrimidinone 1-beta-D-Arabinofuranosyl-Cytosine 1-beta-D-Arabinofuranosylcytosine 1-beta-D-Arabinofuranosylcytosine, Cytosine Arabinoside 1-beta-D-Arabinosyl-Cytosine 1-beta-D-Arabinosylcytosine 147-94-4 1beta -Arabinofuranasylcytosine 1beta -D-Arabinofuranosylcytosine 1beta -D-Arabinosylcytosine 1beta-Arabinofuranasylcytosine 1beta-D-Arabinofuranosylcytosine 1beta-D-Arabinosylcytosine 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl- [CAS] 2(1H)-Pyrimidinone, 4-amino-1- -D-arabinofuranosyl 30399_FLUKA 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin [Czech] 4-Amino-1-arabinofuranosyl-2-oxo-1,2-dihydropyrimidine 4-Amino-1-b-D-arabinofuranosyl-2-(1H)-pyrimidinone 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinon [Czech] 4-Amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one 4-amino-1-beta-D-arabinofuranosylpyrimidin-2(1H)-one 69-74-9 (hydrochloride) AC-1075 AC1L1M4F AC1Q52OJ AI3-52329 AR3 Alexan Ara-C Ara-C, Cytosine Arabinoside, Cytosar-U, Cytarabine Ara-Cytidine AraC Arabinocytidine Arabinofuranosyl Cytidine Arabinofuranosylcytosine Arabinosyl Cytosine Arabinosylcytosine Arabitin Aracytidine Aracytin Aracytine Arafcyt BIDD:GT0371 BIDD:PXR0139 BTB15125 Beta-cytosine arabinoside C02961 C1768_SIGMA C2035 C9H13N3O5 CCRIS 913 CHEBI:28680 CHEMBL803 CHX 3311 CID6253 CPD000449317 CYTARABINE (SEE ALSO CYTARABINE HYDROCHLORIDE 69-74-9) Citarabina Citarabina [INN-Spanish] Cytarabin Cytarabina Cytarabine Cytarabine (JP15/USP/INN) | Cytarabine [USAN:INN:BAN:JAN] Cytarabine liposome injection Cytarabinoside Cytarabinum Cytarabinum [INN-Latin] Cytarbel Cytonal Cytosar Cytosar-U Cytosine 1-beta-D-arabinofuranoside Cytosine arabinofuranoside Cytosine arabinose Cytosine arabinoside Cytosine arabinoside (VAN) Cytosine beta-D-arabinofuranoside Cytosine beta-D-arabinofuranoside hydrochloride Cytosine beta-D-arabinoside Cytosine, beta -D-arabinoside Cytosine, beta-D-arabinoside Cytosine-1-beta-D-arabinofuranoside Cytosine-1-beta-D-arabinofuranoside hydrochloride Cytosine-beta -D-arabinofuranoside Cytosine-beta -arabinoside Cytosine-beta-D-arabinofuranoside Cytosine-beta-arabinoside Cytosinearabinoside D00168 DB00987 DepoCyte Depocyt Depocyt (TN) Depocyt (liposomal) Depocyte EINECS 205-705-9 Erpalfa FT-0082880 HMS2051K19 HMS2090A18 HSDB 3049 Intrathecal (injected into the spinal fluid) DepoCyt Intrathecal cytarabine (also known as ara-C) Iretin LS-860 Lopac0_000316 MLS000758310 MLS001066340 MolPort-001-792-509 NCGC00093356-03 NCGC00093356-04 NCGC00093356-05 NCI-C04728 NSC 287459 NSC287459 S1648_Selleck SAM001247012 SMR000449317 SR-01000075773-3 Spongocytidine TL8001048 Tarabine U 19920A U-19,920 U-19920 UNII-04079A1RDZ Udicil ZINC03795098 beta -D-arabinosylcytosine beta -arabinosylcytosine beta -cytosine arabinoside beta-Ara C beta-Ara c beta-Arabinosylcytosine beta-Cytosine arabinoside beta-D-Arabinosylcytosine cytarabine cytarabine liposome injection cytosine-β-D-arabinofuranoside |
| | 17 | | Daunorubicin | approved | Phase 4, Phase 3, Phase 2 | 252 | 20830-81-3 | 30323 | (+)-Daunomycin (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside (7S,9R)-9-Acetyl-7-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyrannosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-napthacenedione (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro--6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione 11006-54-5 11048-29-6 1407-15-4 149541-57-1 20830-81-3 23942-76-9 27576-81-4 28020-80-6 AB00514669 AC1L1JCP AC1Q29OI AI3-52942 Acetyladriamycin Anthracyline Antibiotics From Streptomyces Coeruleorubidus Antibiotics from Streptomyces coeruleorubidus BPBio1_000389 BRD-K43389675-003-02-7 BRN 1445583 BSPBio_000353 C01907 CCRIS 914 CHEBI:41977 CHEMBL178 CID30323 Cerubidin Cerubidine D07776 DAUNORUBICIN HCL DB00694 DM1 Daunamycin Daunarubicinum Dauno-Rubidomycine DaunoXome DaunoXome (TN) Daunoblastin Daunoblastine Daunomycin | Daunomycin Hydrochloride Daunomycin, Hydrochloride Daunorrubicina Daunorubicin Daunorubicin (INN) Daunorubicin (liposomal) Daunorubicin Hcl Daunorubicin Hydrochloride Daunorubicin [INN:BAN] Daunorubicin, Hydrochloride Daunorubicina Daunorubicine Daunorubicinum Daunorubicinum [INN-Latin] Daunoxome EINECS 244-069-7 FI 6339 FI6339 HMS2089H04 HMS2091K06 HSDB 5095 LMPK13050002 LS-187381 LS-997 Leukaemomycin C MolPort-002-533-961 NCGC00024246-05 NCGC00024246-06 NCGC00025173-01 NCI-C04693 NChemBio.2007.10-comp14 NSC 83142 NSC-82151 Ondena Prestwick3_000487 RCRA waste no. U059 RP 13057 Rcra Waste No. U059 Rp 13057 Hydrochloride Rubidomycin Rubidomycin Hydrochloride Rubomycin Rubomycin C Tocris-1467 UNII-ZS7284E0ZP VS-103 daunorubicin nchembio723-comp2 |
| | 18 | | Dasatinib | approved, investigational | Phase 4, Phase 2, Phase 3, Phase 1 | 268 | 302962-49-8 | 3062316 | (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide 1N1 2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide 302962-49-8 AC1MI3ET AC1Q2P0C AmbotzLS-1203 Anh. dasatinib Anhydrous dasatinib BCB03_000715 BMS 354825 BMS dasatinib BMS-354825 BMS-354825, Sprycel, BMS354825, Dasatinib BMS354825 C488369 CHEBI:49375 CHEMBL1421 CID3062316 D03658 DB01254 Dasatinib Dasatinib (USAN) Dasatinib (anh.) Dasatinib [USAN] Dasatinib anhydrous Dasatinib, BMS 354825 | Dasatinibum EC-000.2122 EN002710 FT-0084503 I14-1972 Kinome_3650 LS-186641 LS-187028 LS-187773 MolPort-003-846-143 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE N-(2-CHLORO-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide NCGC00181129-01 NSC-732517 NSC732517 S1021_Selleck SPRYCEL (TN) Sprycel Spyrcel UNII-X78UG0A0RN dasatinib dasatinibum nchembio.117-comp11 nchembio.162-comp4 nchembio.332-comp1 |
| | 19 | | Granisetron | approved, investigational | Phase 4, Phase 2 | 71 | 109889-09-0 | 3510 | 1-methyl-N-[(1S,5R)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide 1-methyl-N-[(3-endo)-9-methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide 109889-09-0 AC1NR4P1 APF530 BIDD:GT0272 BRL-43694 C07023 CHEMBL519643 CID5284566 D04370 Granisetron | Granisetron (USAN/INN) Granisetron HCl Granisetron Hydrochloride Granisetron base Granisetron hydrochloride Granisetronum Granisetronum [INN-Latin] HMS2089P14 Kytril MolPort-005-943-366 SID90340785 Sancuso granisetron | |
| | 20 | | Esomeprazole | approved, investigational | Phase 4, Phase 1 | 308 | 161796-78-7 | 4594, 9579578 | ( -)-Omeprazole (-)-Omeprazole (-)-omeprazole (S)-(-)-Omeprazole (S)-(−)-omeprazole (S)-Omeprazole (S)-omeprazole (s)-omeprazole (−)-omeprazole 119141-88-7 119141-89-8 131959-78-9 172964-80-6 193469-77-1 2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole 2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole 326602-80-6 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole 5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole 5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1-methyl-1H-benzimidazole 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole 73590-58-6 AC-401 AC1L1IIJ AGI-010 AKOS005066653 AULCER Antra Antra MUPS Audazol Axagon BIDD:GT0020 BIDD:GT0189 BPBio1_000425 BRD-A55962179-001-04-9 BSPBio_000385 Belmazol Bio-0888 C07324 CAS-73590-58-6 CCRIS 7099 CHEBI:50275 CHEBI:519601 CHEBI:7772 CHEMBL1503 CID4594 CID9568614 CID9579578 CPD000058847 Ceprandal D00455 D07917 DB00338 DB00736 DM-3458 Danlox Demeprazol Desec Dizprazol Dudencer Elgam Emeproton Emilok Epirazole Erbolin Esomeprazol Esomeprazole Esomeprazole (INN) Esomeprazole Sodium Esomeprazole [INN:BAN] Esomeprazolum Esomperazole Esopral Exter Gasec Gastrimut Gastroloc Gibancer H 168-68 H 168/68 H-168/68 H168/68 HMS1528I05 HMS1569D07 HMS2052G17 HMS2090E16 HMS2090F11 HSDB 3575 I06-0705 IDI1_032523 InChI=1/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20 Indurgan Inexium paranova Inexium paranova (TN) Inhibitron Inhipump LS-185188 LS-7629 Lensor Logastric Lomac Losec Losec, Omesec, Prilosec, Zegerid, Omeprazole Lucen MLS000069373 MLS001076112 MLS001424148 Maybridge4_002645 Mepral | Miol Miracid MolPort-003-666-741 MolPort-003-807-515 MolPort-003-849-702 MolPort-005-943-880 Mopral Morecon NCGC00016925-01 NCGC00016925-02 NCGC00021522-03 NCGC00021522-04 NCGC00021522-05 Nexiam Nexium Nexium Control Nexium I.V. Nexium IV Nilsec Nopramin Nuclosina O0359 O104_SIGMA OMEP OMZ Ocid Olexin Olit Omapren Omebeta Omebeta 20 Omed Omegast Omepradex Omepral Omeprazol Omeprazol [INN-Spanish] Omeprazole (JAN/USP/INN) Omeprazole [USAN:INN:BAN:JAN] Omeprazole delayed-release Omeprazole magnesium Omeprazolum Omeprazolum [INN-Latin] Omeprazon Omeprazone Omeprol Omesek Omez Omezol Omezolan Omid Omisec Omizac Ompanyt Ortanol Osiren Ozoken Paprazol Parizac Pepticum Pepticus Peptilcer Perprazole Prazentol Prazidec Prazolit Prestwick0_000493 Prestwick1_000493 Prestwick2_000493 Prestwick3_000493 Prestwick_808 Prilosec Prilosec (TN) Prilosec OTC Procelac Proclor Prysma Ramezol Regulacid Result S1389_Selleck SAM001246900 SAN-15 SMR000058847 SPBio_002306 STK623746 Sanamidol Secrepina TL8005099 Tedec Ulceral UNII-KG60484QX9 UNII-N3PA6559FT UPCMLD-DP075 UPCMLD-DP075:001 Ulceral Ulcesep Ulcometion Ulcozol Ulcsep Ulsen Ultop Ulzol Victrix ZINC04693574 ZINC04693575 Zefxon Zegerid Zepral Zimor Zoltum esomeprazol esomeprazole esomeprazolum omeprazole Ésoméprazole | |
| | 21 | | Fosaprepitant | approved | Phase 4, Phase 2, Phase 1, Phase 0 | 154 | 172673-20-0 | 219090 | Fosaprepitant dimeglumine | Fosaprepitantum L-758,298 L-758298 |
| | 22 | | Aprepitant | approved, investigational | Phase 4, Phase 2, Phase 1, Phase 0 | 154 | 170729-80-3 | 151165, 6918365 | 170729-80-3 221350-96-5 3-(((2R,3S)-3-(P-Fluorophenyl)-2-(((alphar)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(2)-1,2,4-triazolin-5-one 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one 3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(sup 2)-1,2,4-triazolin-5-one 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one 5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one 5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one AC1L45SL AC1OCFCG Aprepitant Aprepitant (JAN/USAN/INN) Aprepitant [USAN] Aprepitantum Aprépitant CHEBI:323967 CHEBI:499361 CHEMBL135613 CHEMBL1471 CHEMBL249465 CID11214788 CID11318675 | CID151165 CID6918365 CID9936947 CID9936948 D02968 DB00673 Emend Emend (TN) HMS2090N12 I06-1151 L 754030 L-754030 LS-156477 MK 0869 MK 869 MK-0517 MK-0869 MK-869 MK-869, L-754030, Emend, Aprepitant MolPort-006-392-367 NCGC00181785-01 ONO-7436 S1189_Selleck UNII-1NF15YR6UY |
| | 23 | | Melphalan | approved | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 685 | 148-82-3 | 4053, 460612 | (2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid (2s)-2-amino-3-(4-[bis(2-chloroethyl)amino]phenyl)propanoic acid 148-82-3 3-(P-(Bis(2-chloroethyl)amino)phenyl)-L-alanine 3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine 3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine 3-P-(Di(2-chloroethyl)amino)-phenyl-L-alanine 3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine 3025 C.B. 3025 c.b 3223-07-2 4-(Bis(2-chloroethyl)amino)-L-phenylalanine 4-14-00-01689 (Beilstein Handbook Reference) 4-[Bis(2-chloroethyl)amino]-L-phenylalanine 4-[Bis-(2-chloroethyl)amino]-L-phenylalanine AC1LA2OE ALKERAN (TN) AY3360000 Alanine Nitrogen Mustard Alkeran AmbotzHAA1563 At-290 BIDD:GT0044 BRD-K87827419-001-02-8 BRN 2816456 BSPBio_002407 C13H18Cl2N2O2 CB 3025 CB-3025 CCRIS 374 CHEBI:165415 CHEBI:28876 CHEMBL852 CID460612 D00369 DivK1c_000653 EINECS 205-726-3 HMS2090B09 HMS2091B16 HMS502A15 HSDB 3234 IDI1_000653 KBio1_000653 KBio2_000877 KBio2_003445 KBio2_006013 KBio3_001627 KBioGR_001284 KBioSS_000877 L-3-(P-(Bis(2-chloroethyl)amino)phenyl)alanine L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine L-3-(para-(Bis(2-chloroethyl)amino)phenyl)alanine L-PAM L-Phenylalanine mustard L-Sarcolysin L-Sarcolysine L-Sarkolysin LS-15868 LS-865 Levofalan | Levofolan Levopholan M2011_SIGMA MELPHALAN (SEE ALSO TRANSGENIC MODEL EVALUATION (MELPHALAN)) MLS001333666 MLS002153368 Melfalan Melfalano Melfalano [INN-Spanish] Melphalan (JP15/USP/INN) Melphalan Hydrochloride Melphalan [USAN:INN:BAN:JAN] Melphalan hydrochloride Melphalanum Melphalanum [INN-Latin] Mephalan MolPort-003-665-535 NCGC00090757-01 NCGC00090757-02 NCGC00090757-03 NCI-C04853 NINDS_000653 NIOSH/AY3360000 NSC 241286 NSC 8806 NSC-8806 NSC241286 NSC8806 P-Di-(2-chloroethyl)amino-L-phenylalanine P-L-Sarcolysin P-N-Bis(2-chloroethyl)amino-L-phenylalanine Phenylalanine mustard Phenylalanine nitrogen mustard Prestwick_1006 RCRA waste no. U150 Rcra waste number U150 SK-15673 SMP2_000174 SMR000058720 SPBio_000287 SPECTRUM1500382 Sarcolysine Sarkolysin Spectrum2_000074 Spectrum3_000684 Spectrum4_000882 Spectrum5_001601 Spectrum_000397 TL8001065 TRANSGENIC LEP (MELPHALAN) (SEE ALSO MELPHALAN) TRANSGENIC MODEL EVALUATION (MELPHALAN) UNII-Q41OR9510P melphalan p-Bis(beta-chloroethyl)aminophenylalanine p-Di-(2-chloroethyl)amino-L-phenylalanine p-L-Sarcolysin p-L-sarcolysine p-N,N-bis(2-chloroethyl)amino-L-phenylalanine p-N-Bis(2-chloroethyl)amino-L-phenylalanine p-N-Di(chloroethyl)aminophenylalanine p-N-di(chloroethyl)aminophenylala nine phenylalanine nitrogen mu stard |
| | 24 | | Infliximab | approved | Phase 4 | 349 | 170277-31-3 | | Ig gamma-1 chain C region | Inflectra Remicade Remsima |
| | 25 | | Cisplatin | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 2540 | 15663-27-1 | 84093, 441203, 2767 | (SP-4-1)-diamminedichloridoplatinum (SP-4-1)-diamminedichloroplatinum (SP-4-2)-diamminedichloridoplatinum (SP-4-2)-diamminedichloroplatinum Abiplatin Biocisplatinum Briplatin CACP CDDP CHEBI:35852 CID441203 CPD0-1392 CPDC CPDD Carboquone Cis Pt II Cis-DDP Cis-Diaminedichloroplatinum Cis-Diamminedichloroplatinum Cismaplat Cisplatin Cisplatine Cisplatino Cisplatinum Cisplatyl Citoplationo DB00515 DDP DDPT Diamminedichloroplatinum | EU-0100918 Lederplatin Neoplatin Peyrone's chloride Peyrone's salt Plastin Platamine Platiblastin Platidiam Platinex Platinol Platinol-AQ Platinol-aq Platinoxan Platinum Ammine Chloride Platinum Ammonium Chloride Platinum Diamine Dichloride Randa Trans-DDP Trans-Diaminedichloroplatinum Trans-Diamminedichloroplatinum Trans-Dichlorodiammine Platinum Trans-Platinumdiammine Dichloride cis-DDP cis-Diamminedichloroplatinum cis-Dichlorodiammineplatinum(II) cis-[PtCl2(NH3)2] cis-diamminedichloridoplatinum(II) cis-diamminedichloroplatinum(II) nchembio773-comp1 trans-diamminedichloridoplatinum(II) | |
| | 26 | | Amoxicillin | approved | Phase 4, Phase 2 | 391 | 26787-78-0 | 33613, 2171 | (-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 26787-78-0 33911-69-2 34642-77-8 (mono-hydrochloride salt) 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D- (8CI) 6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid 6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin 6-(P-Hydroxy-alpha-aminophenylacetamido)penicillanic acid 6-(a-Amino-4-hydroxyphenylacetamido)penicillanic acid 6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid 6-(p-hydroxy-α-aminophenylacetamido)penicillanic acid 6-[[Amino(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 9CI 61336-70-7 (TRIHYDRATE) 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid 71447-36-4 81030-75-3 AC-12263 AC1L1PY2 AMC AMOXICILLIN CRYSTALLINE AMOXICILLIN PEDIATRIC AMPC AUGMENTIN '125' AUGMENTIN '200' AUGMENTIN '250' AUGMENTIN '400' AUGMENTIN '500' AUGMENTIN '875' AUGMENTIN ES-600 AX Actimoxi Almodan Ambap26787-78-0 Amix Amoclen Amolin Amopen Amopenixin Amoram Amox Amox 250 Cap 250mg Amox 500 Cap 500mg Amox S 125 Sus 125mg/5ml Amox S 250 Sus 250mg/5ml Amoxi Amoxi-Mast Amoxi-mast Amoxibiotic Amoxicaps Amoxicilina Amoxicilina [INN-Spanish] Amoxicillin Amoxicillin (INN) Amoxicillin (TN) Amoxicillin (anhydrous) Amoxicillin (inn) Amoxicillin Extended-release Amoxicillin Trihydrate Amoxicillin and clavulanate potassium Amoxicillin anhydrous Amoxicillin pediatric Amoxicillin sodium Amoxicillin trihydrate Amoxicillin(usan) Amoxicilline Amoxicilline [INN-French] Amoxicilline [INN] Amoxicilline [inn] Amoxicillinum Amoxicillinum [INN-Latin] Amoxid Amoxiden Amoxil Amoxivet Amoxycillin Amoxycillin Trihydrate Amoxycillin trihydrate Amoxycillin, BAN Amoxymed Amrit Anemolin Apo-Amoxi Apo-Amoxi Cap 250mg Apo-Amoxi Cap 500mg Apo-Amoxi Pwr for Susp 125mg/5ml Apo-Amoxi Pwr for Susp 250mg/5ml Apo-amoxi Apo-amoxi sugar free Aspenil Augmentinxr BL-P 1410 BLP 1410 BPBio1_000499 BRD-K55044200-001-03-9 BRL 2333 | BRL-2333 BSPBio_000453 Biomox Bristamox C06827 CHEBI:2676 CHEBI:53712 CHEMBL1082 CID33613 CPD000058707 Cemoxin Clamoxyl Clamoxyl (SKB) D-(-)-alpha-Amino-p-hydroxybenzyl penicillin D-(-)-alpha-Amino-p-hydroxybenzylpenicillin D-(alpha-Amino-p-hydroxybenzyl)penicillin D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid D-Amoxicillin D07452 DB01060 Delacillin DisperMox Dispermox EINECS 248-003-8 Efpenix Flemoxin Galenamox Gen-Amoxicillin 250mg Gen-Amoxicillin 500mg HMS1569G15 HSDB 3204 Hiconcil Histocillin Hydroxyampicillin Ibiamox Imacillin LS-149721 Lamoxy Larotid MLS000028632 MLS002222248 Metafarma capsules Metifarma capsules MolPort-003-981-182 MolPort-005-933-687 Moxacin Moxal Moxatag NCGC00179554-01 NSC 277174 NSC277174 Novamoxin Novamoxin Cap 250mg Novamoxin Cap 500mg Novamoxin Sus 125mg/5ml Novamoxin Sus 250mg/5ml Nu-Amoxi Cap 250mg Nu-Amoxi Cap 500mg Nu-Amoxi Sus 125/5ml Nu-Amoxi Sus 250mg/5ml Ospamox P-Hydroxyampicillin PHL-amoxicillin PMS-amoxicillin Pamoxicillin Piramox Polymox Prestwick0_000357 Prestwick1_000357 Prestwick2_000357 Prestwick3_000357 Prestwick_713 Prevpac Pro Amox Pwr for Oral Susp 125mg/5ml Pro Amox-250 Cap 250mg Pro Amox-500 Cap 500mg Pro-Amox-250 Orl Sus 250mg/5ml R-Hydroxyampicillin Rimoxallin Ro 10-8756 Robamox SAM002264592 SMR000058707 SPBio_002374 Sauracillin Sawamox PM Sumox Tolodina Trimox Unicillin Utimox Vetramox Wymox Zimox alpha-Amino-p-hydroxybenzylpenicillin alpha-amino-P-Hydroxybenzylpenicillin amoxicillanyl amoxicillin p-Hydroxyampicillin α-amino-p-hydroxybenzylpenicillin |
| | 27 | | Hydrocortisone | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 583 | 50-23-7 | 5754, 657311 | (11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione 1 Hydrocortisone maximum strength 11-Hydrocortisone 11-beta-Hydrocortisone 11-beta-Hydroxycortisone 11a-Hydroxycorticosterone 11alpha-Hydroxycorticosterone 11b,17,21-Trihydroxyprogesterone 11b-Hydrocortisone 11b-Hydroxycortisone 11beta,17,21-Trihydroxyprogesterone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione 11beta-Hydrocortisone 11beta-Hydroxycortisone 11beta-hydrocortisone 11β-hydrocortisone 17-Hydroxycorticosterone 17a-Hydroxycorticosterone 17alpha-Hydroxycorticosterone 2v95 4-Pregnen-11beta,17alpha,21-triol-3,20-dione 4-Pregnene-11alpha,21-triol 3,20-dione 4-Pregnene-11b,17a,21-triol-3,20-dione 50-23-7 8056-08-4 80562-38-5 8063-42-1 999 Itch Relieving A-hydrocort AC-12902 AC1L1L2B ACETASOL HC ACETIC ACID W/ HYDROCORTISONE AI3-25006 AKOS001582651 Acticort Acticort (TN) Advanced Hydrocortisone Aeroseb HC Aeroseb-HC Ala-Cort Ala-Scalp Alacort Algicirtis Alphaderm Amberin Anflam Anti Itch Anti Itch maximum strength Anti Itch maximum strength plus Anti-inflammatory hormone Anti-itch Anti-itch Scalp Relief Maximum Strength Anucort Anucort-HC Anusol HC Anusol HC (TN) Apres Peel Soothing Balm Aquacort Aquanil HC Atopalm Maximum Strength Anti-itch Atopalm Moisturizing Hydrocortisone Aveeno Hydrocortisone Anti Itch B48448A1-24BA-47CA-8D9E-43E5BC949386 BPBio1_000544 BRD-K93568044-001-03-1 BSPBio_000494 Balneol-hc Barseb HC Basan-Corti Beta-hc Bio-0648 Bioelements Immediate Comfort Hydrocortisone Budpak Anti-itch C00735 C21H30O5 CCRIS 5854 CHEBI:17650 CHEMBL389621 CID5754 COR-OTICIN CPD000653523 CaldeCORT Spray Caldecort Care One Hydrocortisone maximum strength Cetacort Chronocort Cicatricure Ultra Moisturizing Clear aid Cleiton Cobadex Colocort Colocort (TN) Compound F Compound F (kendall) Cor-Tar-Quin Corhydron Cort-Dome Cort-Quin Cortaid 12-hour Advanced Anti-Itch Cortaid Intensive Therapy Cooling Cortaid Maximum Strength Cortanal Cortef Cortef (TN) Cortenema Cortesal Corticreme Cortifair Cortifan Cortifoam Cortiment Cortisol Cortisol alcohol Cortisol, Hydrocortisone Cortisolonum Cortisone Cortisone Cream Intensive Healing Cortisone Maximum Strength Cortisone maximum strength Cortisporin Cortisporin Otico Cortispray Cortizol Cortizone 10 Cortizone 10 Cooling Cream Anti-itch Cortizone 10 Cooling Relief Cortizone 10 Easy Relief Cortizone 10 Hydratensive Healing Anti Itch Cortizone 10 Hydratensive Soothing Anti Itch Cortizone 10 Intensive Healing Cortizone 10 Intensive Healing Feminine Itch Relief Cortizone 10 Intensive Healing For Eczema Cortizone 10 Plus Cortizone 10 Poison Ivy Relief Pads Cortolotion Cortonema Cortoxide Cortril Cremesone Cremicort-H Cutisol Cvs Anti-itch Hydrocortisone Cvs Cools Itch Fast Cvs Cortisone Cvs Pharmacy Anti-itch Cyclodextrin-encapsulated hydrocortisone D00088 DB00741 DB07886 Delacort Derm-Aid Dermacort Dermacort Anti-Itch Dermaquest Skin Therapy Post-skin Resurfacing Balm Dermarest Eczema Medicated Dermaspray Dermil Dermocortal Dermolate Dg Health Hydrocortisone Dg Health Hydrocortisone Cream Maximum Strength Dihydrocostisone Dioderm Dome-cort Domolene-HC Dr. Sheffield Hydrocortisone Anti Itch Drotic Duane Reade Duane Reade hydrocortisone Duane Reade hydrocortisone plus 12 moisturizers DuoCort EINECS 200-020-1 EU-0100594 Ef corlin Efcorbin Efcortelan Efcortelin Eldecort Eldercort Epicort Epicortisol Epiderm H Equaline Anti Itch Equaline Anti Itch maximum strength Equate Hydrocortisone Esiderm H Evacort Family Care Hydrocortisone Family Wellness Family Wellness Hydrocortisone Family Wellness Maximum Strength Hydrocortisone Ficortril Fiocortril Fixmyskin Healing Balm Fragrance-free Fixmyskin Healing Balm Unflavored Fixmyskin Healing Balm Vanilla Flavor Fixmyskin Healing Balm Vanilla Fragrance Flexicort Foille Insetti Formu Care Anti Itch maximum strength Fulton Street Market Anti Itch Genacort Genacort (lotion) Genuine Hydrocortisone Glycort Good Neighbor Pharmacy Anti Itch Good Neighbor Pharmacy Hydrocortisone Good Neighbor Pharmacy Hydrocortisone Plus 12 Moisturizers Good Sense Anti Itch Gyno-Cortisone H 4001 H-Cort H-releve Anti-itch H0135_SIGMA H0396_SIGMA H0888_SIGMA H3160_SIGMA H4001_SIGMA H6909_SIGMA HC HC #1 HC #4 HC (HYDROCORTISONE) HMS1569I16 HMS2090M04 HSDB 3339 HYDROCORTISONE AND ACETIC ACID HYDROCORTISONE IN ABSORBASE Healerz For Itches Health Mart Pharmacy Hydrocortisone Maximum Strength Plus 12 Moisturizers Healthy Accents Cortisone maximum strength Heb Cort Heb-Cort | Hem-easy Relief Herbal Anti-itch Maximum Itch Relief Hi-cor Hidalone Hidro-Colisona Hidrocortisona Hidrocortisona [INN-Spanish] Hycort Hycortol Hycortole Hydracort Hydrasson Hydro Skin Hydro-Adreson Hydro-Colisona Hydro-RX Hydro-colisona Hydrocort Hydrocortal Hydrocorticosterone Hydrocortisone Hydrocortisone (JP15/USP/INN) Hydrocortisone 1 plus 10 Hydrocortisone Acetate Hydrocortisone Anti-itch Plus Hydrocortisone Base Hydrocortisone Butyrate Hydrocortisone D Hydrocortisone HC Hydrocortisone Intensive Healing Formula Hydrocortisone Maximum Strength Hydrocortisone Maximum Strength Plus 12 Moisturizers Hydrocortisone Plus Hydrocortisone Plus 12 Moisturizers Hydrocortisone Probutate Hydrocortisone Regular Strength Hydrocortisone Sodium Phosphate Hydrocortisone Ultra Strength Hydrocortisone Valerate Hydrocortisone [INN:BAN:JAN] Hydrocortisone alcohol Hydrocortisone anti itch Hydrocortisone base Hydrocortisone free alcohol Hydrocortisone maximum strength Hydrocortisone solution Hydrocortisone-Water Soluble Hydrocortisonum Hydrocortisonum [INN-Latin] Hydrocortistab Hydrocortisyl Hydrocortone Hydroskin Hydroxycortisone Hysone Hytisone Hytone Hytone (TN) Hytone lotion Idrocortisone Idrocortisone [DCIT] Incortin-H Incortin-hydrogen Intensive Healing Anti Itch Kaiser Permanente Hydrocortisone Kendall'S compound F Kendall's compound F Kera Hc Hydrocortisone Kirkland Signature Hydrocortisone Plus maximum strength Komed HC Kyypakkaus LMST02030001 LS-7439 Lacticare HC Lacticare-HC Lactisona Leader Hydrocortisone Locoid Loesch Anti-Itch Therapy Lopac0_000594 Lubricort Lucky Supersoft MAXIMUM STRENGTH MLS000069609 MLS001148103 MLS002207135 MLS002222189 Maintasone Makesense MAXIMUM STRENGTH Maximum Strength Cortizone 10 Quick Shot 360 Continuous Maximum Strength Hydrocortisone Maximum-h Medicort Medpride Meijer Anti Itch Meijer Anti Itch Cream Plus Meijer Hydrocortisone Meijer Hydrocortisone Plus 12 Moisturizers Members Mark Hydrocortisone Meusicort Mildison Milliderm MolPort-001-794-637 Monistat Complete Care Instant Itch Relief NCGC00022848-06 NCGC00022848-07 NCGC00022848-09 NCGC00022848-12 NCI60_000118 NSC 10483 NSC-10483 NSC10483 Natureplex Hydrocortisone Hydro Neo-Cort-Dome Neo-Cortef Neosporin Eczema Essentials Anti Itch Neosporin-H Ear Nogenic HC Nu-derm Tolereen Anti-pruritic Nutracort Nystaform-HC ORLEX HC Optef Otalgine Otic-Neo-Cort-Dome Otobiotic Otocort Otosone-F Pandel Pediaderm Hc Pediotic Suspension Penecort Permicort Piyanping Antiitch Polcort H Premier Value Hydrocortisone Premier Value Hydrocortisone Plus 12 Moisturizers Preparation H Hydrocortisone Preparation H Hydrocortisone Cream Prepcort Prestwick0_000447 Prestwick1_000447 Prestwick2_000447 Prestwick3_000447 Prestwick_265 Prevex HC Proactiv Solution Anti-itch Scalp Procto-pak Proctocort Proctocream HC Proctofoam Proctosol-hc Proctozone HC Procure Protocort Publix Hydro Publix hydro plus Quadrydern Quality Choice Hydrocortisone Quality Choice Hydrocortisone Maximum Strength Quality Choice Maximum Strength Anti Itch Racet Rectasol-HC Rectoid Refuge Hc Reichstein'S substance M Reichstein's substance M Remederm HC Rexall Anti Itch maximum strength relief Rexall Hydrocortisone 1 Rexall Hydrocortisone plus moisturizers Rite Aid anti-itch S1696_Selleck SAM002264617 SMP1_000156 SMR000059022 SMR000653523 SPBio_002433 Safeway Hydrocortisone Plus 12 Moisturizers Sanatison Scalp-Cort Scalpicin Anti-Itch Maximum Strength Scalpicin Capilar Scalpicin Maximum Strength Scalpicin Scalp Itch Medication Maximum Strength Schericur Scheroson F Shopko Hydrocortisone Shopko Hydrocortisone Intensive Healing Formula Shopko Hydrocortisone Maximum Strength Shopko Hydrocortisone Plus 12 Moisturizers Maximum Strength Shopko Maximum Strength Shoprite Hydrocortisone Sigmacort Signef Smart Sense Anti Itch Smart Sense Anti Itch maximum strength Smart Sense Hydrocortisone Solu-cortef Soothe Rodan Fields Stie-cort Stiefcorcil Sunmark Hydrocortisone Sunmark Hydrocortisone Plus 12 Moisturizers Synacort Systral Hydrocort Tarcortin Tecnu Corticool Texacort Texacort lotion 25 Thera Plus Timocort Topcare Hydrocortisone Topcare Hydrocortisone Intensive Healing Formula Topcare Hydrocortisone Plus 12 Moisturizers Topicort Transderma H Traumaide Truelipids Anti-itch Barrier U-cort UNII-WI4X0X7BPJ UPCMLD-DP133 UPCMLD-DP133:001 Uniderm Vioform-Hydrocortisone VoSol HC Vytone Walgreens Hydrocortisone Plus 12 Moisturizers Westcort Western Family HydroCortisone Western Family HydroCortisone Plus 12 Moisturizers Zenoxone [3H]cortisol component of Lubricort component of Neo-Cort-Dome component of Otalgine hydrocortisone | |
| | 28 | | Fludarabine | approved | Phase 4, Phase 3, Phase 2, Phase 1 | 1059 | 21679-14-1, 75607-67-9 | 30751 | (2R,3S,4S,5R)-2-(6-amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol 2-F-ara-A 2-Fluoro Ara-A 2-Fluoro-9-beta-D-arabinofuranosyladenine 2-Fluoro-ara AMP 2-Fluoroadenine arabinoside 5'-monophosphate 21679-14-1 2F-Ara-AMP 9-beta-Arabinofuranosyl-2-fluoroadenine-5'-phosphate 9-beta-D-Arabinofuranosyl-2-fluoroadenine 9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-(dihydrogen phosphate) 9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-monophosphate 9-beta-D-arabinofuranosyl-2-fluoro-9H-purin-6-amine 9H-Purin-6-amine, 9-beta-D-arabinofuranosyl-2-fluoro- (9CI) AC1LCW8I AC1Q51CF C10H12FN5O4 CCRIS 3382 CHEMBL1568 CID657237 CPD000058874 D07966 EINECS 244-525-5 F-Ara-A FAMP FT-0082766 FaraA Fludara | Fludara, Fludarabine Fludarabina Fludarabina [Spanish] Fludarabine Fludarabine (INN) Fludarabine 5'-monophosphate Fludarabine Phosphate Fludarabine [INN] Fludarabine monophosphate Fludarabine phosphate Fludarabinum Fludarabinum [Latin] Fludura Fluradosa Fluradosa (TN) HSDB 6964 I14-4978 LS-15061 MLS000028687 NSC 118218 NSC 118218H NSC-118218 Oforta S1491_Selleck SAM002548956 SMR000058874 SQ Fludarabine UNII-1X9VK9O1SC UNII-P2K93U8740 ZINC04216238 | |
| | 29 | | Idarubicin | approved | Phase 4, Phase 3, Phase 2 | 199 | 58957-92-9 | 42890 | (1S,3S)-3-Acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydronaphthacen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (1S,3S)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside (1s,3s)-3-acetyl-3,5,12-trihydroxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-|A-l-lyxo-hexopyranoside (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione (7S-cis)-9-Acetyl-7-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,9,11-trihydroxy-5,12-naphthacenedione 4-DMD 4-Demethoxydaunomycin 4-Demethoxydaunorubicin 4-Desmethoxydaunorubicin 57852-57-0 57852-57-0 (HYDROCHLORIDE) 58957-92-9 AC1L28SA AC1Q6JJ4 BRD-K69650333-001-01-1 C26H27NO9 CCRIS 5083 CHEBI:42068 CHEMBL1117 CID42890 D08062 DB01177 DM5 DMDR EU-0100600 HMS2089D05 I 1656 I06-1097 I1656_SIGMA IDARUBICIN IMI 30 | IMI-30 Idamycin Idamycin PFS Idarubicin Idarubicin (INN) Idarubicin Aglycone Idarubicin HCl PFS Idarubicin Hcl Idarubicin Hcl Pfs Idarubicin Hydrochloride Idarubicin [INN:BAN] Idarubicina Idarubicina [INN-Spanish] Idarubicine Idarubicine [INN-French] Idarubicinum Idarubicinum [INN-Latin] KBioSS_002388 LS-94015 Lopac0_000600 MLS000759470 NCGC00093976-01 NCGC00093976-02 NCGC00093976-03 NCGC00093976-04 NSC-256439 NSC256439 SMR000466355 UNII-ZRP63D75JW Zavedos Zavedos (TN) idarubicin hydrochloride | |
| | 30 | | Mitoxantrone | approved, investigational | Phase 4, Phase 3, Phase 2, Phase 1 | 257 | 65271-80-9 | 4212 | 1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE 1,4-DIHYDROXY-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-anthracenedione 1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione 1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon 1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione 1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthra-9,10-quinone 1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione 137635-96-2 2fum 5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone 65271-80-9 70476-82-3 70476-82-3 (hydrochloride) 70711-41-0 70711-41-0 (acetate) 70945-62-9 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (9CI) AB00053716 AC1L1HNY AN-584/42007670 BIDD:PXR0181 BPBio1_000627 BRD-K21680192-300-05-2 BRD-K21680192-300-07-8 BRN 2795126 BSPBio_000569 BSPBio_003160 C11195 C22H28N4O6 CAS-70476-82-3 CCRIS 7604 CHEBI:50729 CHEMBL58 CID4212 D08224 DB01204 DHAD DHAQ DHAQ (*Diacetate salt*) DHAQ HCl Dihydroxyanthraquinone DivK1c_000516 HMS2090D05 IDI1_000516 KBio1_000516 KBio2_002135 KBio2_004703 KBio2_007271 KBio3_002660 KBioGR_001531 KBioSS_002135 LS-20638 Liposome Encapsulated Mitoxantrone (LEM) Lopac-M-6545 Lopac0_000779 MITOXANTRONE, 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE MIX MLS002703044 | Misostol Misostol (TN) Mitox Mitoxanthrone Mitoxantron Mitoxantrona Mitoxantrona [INN-Spanish] Mitoxantrone Mitoxantrone (INN) Mitoxantrone (free base) Mitoxantrone 2HCl Mitoxantrone HCl Mitoxantrone Hydrochloride Mitoxantrone [INN] Mitoxantrone dihydrochloride Mitoxantrone hydrochloride Mitoxantronum Mitoxantronum [INN-Latin] Mitozantrone Mitozantrone hydrochloride MolPort-003-849-239 NCGC00015693-01 NCGC00015693-02 NCGC00015693-04 NCGC00162251-01 NCI60_002276 NCI60_002535 NChemBio.2007.10-comp17 NINDS_000516 NSC 279836 NSC-279836 NSC-287836 NSC-299195 NSC-301739 NSC-301739D NSC279836 NSC299195 NSC301739 Neuro_000153 Novantron Novantrone Novantrone(R) (mitoxantrone for injection concentrate) Prestwick0_000385 Prestwick1_000385 Prestwick2_000385 Prestwick3_000385 S2485_Selleck SMP2_000179 SMR001549953 SPBio_000756 SPBio_002490 SR-01000076001 SR-01000076001-7 STK631833 Spectrum2_000908 Spectrum3_001590 Spectrum4_000866 Spectrum5_001205 Spectrum_001655 UNII-BZ114NVM5P VU0244399-2 mitoxantrone | |
| | 31 | | Palonosetron | approved, investigational | Phase 4, Phase 2 | 80 | 119904-90-4 | 148211 | (3aR)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one (3aS)-2,3,3a,4,5,6-hexahydro-2-[(3S)-3-quinuclidinyl]-1H-benz[de]isoquinolin-1-one (3aS)-2-[(3S)-1-azabicyclo[2.2.2]oct-3-yl]-2,3,3a, 4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one (S-(R*,R*))-2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one 135729-56-5 135729-61-2 2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one 2-Qhbiqo AC1L3WNN Aloxi CID148211 DB00377 LS-186967 LS-187778 NCGC00166415-01 NCGC00166415-02 | Onicit Palonosetron Palonosetron Hydrochloride Palonosetron [INN] Palonosetronum Palonosetrón Palonosétron RS 25233-197 RS 25233-198 RS 25259-197 RS 25259-198 RS-25233-197 RS-25233-198 RS-25259-197 RS-25259-198 SID50111798 UNII-5D06587D6R | |
| | 32 | | Etoposide | approved | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 1169 | 33419-42-0 | 36462 | (-)-Etoposide 121471-01-0 136598-18-0 201594-04-9 33419-42-0 35317-32-9 4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside) 4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside) 4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside 4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin 4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside 4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside 51854-34-3 76576-58-4 9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one AB00438905 AC1L1FN8 AC1L1VT3 AC1L6246 AC1NR4OG AC1O4WGG AC1O7M1N AC1Q47JJ Ambap33419-42-0 BPBio1_000673 BRD-K37798499-001-02-5 BSPBio_000611 Bio1_000489 Bio1_000978 Bio1_001467 C01576 CCRIS 2392 CHEBI:4911 CHEBI:588795 CHEMBL44657 CID11758093 CID284997 CID3310 CID36462 CID5284558 CID6419930 CID6610299 CPD000112002 D00125 DB00773 DEMETHY-EPIPODOPHYLLOTOXIN,ETHYLIDENE GLUCOSIDE, Demethyl Epipodophyllotoxin Ethylidine Glucoside Demethyl-epiodophyllotoxin ethylidene glucoside Demethylepipodophyllotoxin-beta-D-ethylideneglucoside E0675 E1383_SIGMA EINECS 251-509-1 EPE EPEG ETOP Epipodophyllotoxin Epipodophyllotoxin VP-16213 Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI) Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside) Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside) Eposide Eposin Eposin, Vepesid, VP-16, Toposar, Etoposide | Etopol Etopophos Etopophos (phosphate salt) Etoposid Etoposide Etoposide (JP15/USP/INN) Etoposide (VP16) Etoposide Phosphate Etoposide [USAN:INN:BAN:JAN] Etoposido Etoposido [INN-Spanish] Etoposidum Etoposidum [INN-Latin] Etosid HMS1569O13 HMS2052N05 HMS2089F14 HSDB 6517 I06-0248 KBioSS_002410 LS-1214 Lastet MLS000049957 MLS001074951 MLS001424283 MLS002153463 MLS002207239 MLS002222184 MolPort-003-983-431 MolPort-004-905-001 MolPort-004-955-161 NCGC00025056-02 NChemBio.2007.10-comp19 NK 171 NSC 141540 NSC-141540 NSC141540 Prestwick0_000396 Prestwick1_000396 Prestwick2_000396 Prestwick3_000396 Prestwick_211 S1225_Selleck SAM001246880 SMR000112002 SPBio_002532 ST056353 Toposar UNII-6PLQ3CP4P3 VP 16 VP 16 (pharmaceutical) VP 16-213 VP 16213 VP-16 VP-16-213 VePESID (TN) VePesid Vepesid Vepesid J Vepeside ZINC03830818 ZINC03938684 Zuyeyidal etoposide nchembio.573-comp8 nchembio873-comp2 trans-Etoposide | |
| | 33 | | Mechlorethamine | approved | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 309 | 51-75-2 | 4033 | .Beta.,.beta.'-Dichlorodiethyl-N-methylamine 1, 5-Dichloro-3-methyl-3-azapentane hydrochloride 126-85-2 (N-oxide) 2,2'-Dichloro-N-me 2,2'-Dichloro-N-methyldiethylamine 2,2'-Dichlorodiethyl-methylamine 2,2'-dichloro-N-methyldiethylamine 2-Chloro-N-(2-chloroethyl)-N-methylethanamine 302-70-5 (N-oxide, hydrochloride) 51-75-2 55-86-7 (HYDROCHLORIDE) AC1L1H9H Antimit BRN 0605323 BSPBio_001947 Bis(2-chloroethyl)methylamine Bis(beta-chloroethyl) methylamine Bis(beta-chloroethyl)methylamine C07115 C5H11Cl2N CCRIS 447 CHEBI:28925 CHEMBL427 CID4033 Carolysine Caryolysin Caryolysine Chloramine (the nitrogen mustard) Chlorethazine Chlormethine Chlormethine (INN) Chlormethine [INN:BAN] Chlormethinum [INN-Latin] Cloramin Clormetina Clormetina [INN-Spanish] D07671 DB00888 Di(2-chloroethyl)methylamine Dichlor amine Dichloren DivK1c_000759 EINECS 200-120-5 ENT-25294 Embechine Embichin HMS1920J15 HMS2091B04 HMS502F21 HN-2 HN2 HSDB 5083 I14-8708 IBS-L0033631 IDI1_000759 KBio1_000759 KBio2_001369 KBio2_003937 KBio2_006505 KBio3_001447 KBioGR_001448 | KBioSS_001369 LS-7559 MBA Me chloroethamine Mebichloramine Mechlorethamine Mechlorethamine hydrochloride Mechlorethanamine Mechloroethamine Mecloretamina Mecloretamina [Italian] Methylbis(2-chloroethyl)amine Methylbis(beta-chloroethyl)amine Methyldi(2-chloroethyl)amine Mitoxine (*Hydrochloride*) MolPort-001-785-592 Mustargen Mustine Mustine note Mutagen N,N-Bis(2-chloroethyl)-N-methylamine N,N-Bis(2-chloroethyl)methylamine N,N-Di(chloroethyl)methylamine N-Lost N-Methyl lost N-Methyl-2,2'-dichlorodiethylamine N-Methyl-bis(2-chloroethyl)amine N-Methyl-bis(beta-chloroethyl)amine N-Methyl-bis-chloraethylamin N-Methyl-bis-chloraethylamin [German] N-Methyl-lost N-Methyl-lost [German] N-methyl-bis(2-chloroethyl)amine NCGC00091835-02 NCGC00091835-03 NCGC00091835-04 NCGC00091835-05 NCI60_041682 NINDS_000759 NSC762 Nitol (*Hydrochloride*) Nitrogen mustard Nitrogen mustard (HN-2) Nitrogranulogen SPBio_000496 SPECTRUM1500375 Spectrum2_000448 Spectrum3_000484 Spectrum4_000924 Spectrum5_001702 Spectrum_000889 Stickstofflost (*Hydrochloride*) Stickstofflost (ebewe) T 1024 T-1024 TL 146 UNII-50D9XSG0VR Valchlor beta,Beta'-dichlorodiethyl-N-methylamine beta,beta'-Dichlorodiethyl-N-methylamine mechlorethamine thyldiethylamine β,β'-dichlorodiethyl-N-methylamine |
| | 34 | | Azathioprine | approved | Phase 4 | 153 | 446-86-6 | 2265 | 446-86-6 55774-33-9 (hydrochloride salt) 6-((1-Methyl-4-nitro-1H-imidazol-5-yl)thio)-1H-purine 6-((1-Methyl-4-nitroimidazol-5-yl)thio)purine 6-(1'-Methyl-4'-nitro-5'-imidazolyl)-mercaptopurine 6-(1'-Methyl-4'-nitro-5'-imidazolyl)mercaptopurine 6-(1-Methyl-4-nitroimidazol-5-yl)thiopurine 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin 6-(1-Methyl-4-nitroimidazol-5-ylthio)purin [Czech] 6-(1-Methyl-p-nitro-5-imidazolyl)-thiopurine 6-(1-Methyl-p-nitro-5-imidazolyl)thiopurine 6-(3-Methyl-5-nitro-3H-imidazol-4-ylsulfanyl)-7H-purine 6-(3-methyl-5-nitroimidazol-4-yl)sulfanyl-7H-purine 6-(Methyl-p-nitro-5-imidazolyl)-thiopurine 6-(Methyl-p-nitro-5-imidazolyl)thiopurine 6-({4-nitro-1-methyl-1H-imidazol-5-yl}sulfanyl)-7H-purine 6-1'-Methyl,4'-nitro,5'-imidazolyl mercaptopurine 6-[(1-Methyl-4-nitroimidazol-5-yl)- thio] purine 6-[(1-Methyl-4-nitroimidazol-5-yl)thio]purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)sulfanyl]-7H-purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-Purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-7H-purine 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purine A 4638 A2593_SIAL A4638_SIAL A4638_SIGMA AB00443544 AB00443544-03 AC-4230 AC1L1DAL AC1Q3Z1F AI-981/34845012 AI3-50290 Azamun Azamun [Czech] Azanin Azasan Azasan (TN) Azasan, Imuran, Azamun, BW-57-322, NSC-39084, Azathioprine Azathioprin Azathioprine Azathioprine (JP15/USP/INN) Azathioprine Sodium Azathioprine [USAN:INN:BAN:JAN] Azathioprine sodium Azathioprinum Azathioprinum [INN-Latin] Azathiopurine Azatioprin Azatioprina Azatioprina [INN-Spanish] Azothioprine B. W. 57-322 BPBio1_000054 BRD-K32821942-001-05-6 BRD-K60324116-001-01-5 BSPBio_000048 BSPBio_001876 BW 57-322 BW 57322 BW-57-322 C06837 C9H7N7O2S CAS-446-86-6 CBDivE_013132 CCRIS 62 CHEBI:2948 CHEMBL1542 CID2265 CPD000427366 Ccucol ChemDiv1_002659 Cytostatics D00238 DB00993 DivK1c_000586 EINECS 207-175-4 EU-0100027 FT-0083532 HMS1568C10 | HMS1920E17 HMS2091K19 HMS501N08 HMS594I19 HSDB 7084 IDI1_000586 Immuran Imuran Imuran (TN) Imuran (tn) Imurek Imurel KBio1_000586 KBio2_000464 KBio2_002427 KBio2_003032 KBio2_004995 KBio2_005600 KBio2_007563 KBio3_001376 KBio3_002906 KBioGR_000646 KBioGR_002427 KBioSS_000464 KBioSS_002433 LS-123 Lopac-A-4638 Lopac0_000027 MLS001049307 Methylnitroimidazolylmercaptopurine MolPort-000-745-914 MolPort-000-764-262 MolPort-003-665-485 Muran NCGC00015060-01 NCGC00015060-02 NCGC00015060-04 NCGC00015060-12 NCGC00090836-01 NCGC00090836-02 NCGC00090836-03 NCGC00090836-04 NCGC00090836-05 NCGC00090836-06 NCGC00094593-01 NCGC00094593-02 NCGC00094593-03 NCI-C03474 NINDS_000586 NSC 39084 NSC-39084 NSC39084 Oprea1_375441 Oprea1_533384 Oprea1_633462 Prestwick0_000094 Prestwick1_000094 Prestwick2_000094 Prestwick3_000094 Prestwick_41 S1721_Selleck SAM002589938 SDCCGMLS-0065415.P001 SMR000427366 SPBio_000255 SPBio_001987 SPECTRUM1500133 STK831906 STOCK1S-20293 STOCK1S-27186 Spectrum2_000068 Spectrum3_000308 Spectrum4_000243 Spectrum5_000848 Spectrum_000064 Thiopurine 6-(1-methyl-4-nitroimidazol-5-yl) UNII-MRK240IY2L WLN: T56 BM DN FN HNJ IS- ET5N CNJ A1 DNW ZINC04258316 [Methyl(nitroimidazolyl)mercaptopurine] azathioprine azatiopr in cMAP_000046 |
| | 35 | | Teniposide | approved | Phase 4, Phase 2 | 19 | 29767-20-2 | 34698 | 23362-13-2 29767-20-2 299-36-5 31514-29-1 35317-44-3 4'-Demethyl-epipodophyllotoxin-beta-D-thenylidene-glucoside 4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-2-thenylidene-beta-D-glucopyranoside) 4'-Demethylepipodophyllotoxin 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) 4'-Demethylepipodophyllotoxin thenylidene glucoside 4'-Demethylepipodophyllotoxin-beta-D-thenylidene glucoside 4'-Demethylepipodophyllotoxin-beta-D-thenylidine glucoside 4'-Dimethyl-9-(4,6-O-2-thenyid)-epipodophyllotoxin 4-Demethylepipodophyllotoxin-.beta.-D-thenylideneglucoside 55256-09-2 AC-759 AC1L1K9H AC1L1S3X AC1L32H7 AC1L5IF3 AC1L9QDK AC1NR4S8 AC1O8FOE AR-1A6252 AR-1A6526 Ambap29767-20-2 BRD-A35588707-001-02-2 BSPBio_003436 C11153 C32H32O13S CCRIS 2058 CHEMBL278534 CID107642 CID275784 CID34698 CID452548 CID5284623 CID5396 CID6708778 D02698 DB00444 Demethyl Epipodophyllotoxin Thenylidine Glucoside DivK1c_006888 EINECS 249-831-2 Epidophyllotoxin Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) FT-0080118 HMS1922B15 HMS2093O15 HSDB 6546 | I06-2040 KBio1_001832 KBio2_002029 KBio2_004597 KBio2_007165 KBio3_002939 KBioGR_001050 KBioSS_002029 KST-1A3576 KST-1A5976 LS-63999 MLS000766234 MolPort-003-666-525 MolPort-005-940-276 MolPort-006-822-656 NCI60_000540 NSC 122819 NSC 12819 NSC-122819 NSC122819 Neuro_000056 PTG S1787_Selleck SMR000528847 SPBio_001773 SPECTRUM1504094 SpecPlus_000792 Spectrum2_001647 Spectrum3_001898 Spectrum4_000585 Spectrum5_001111 Spectrum_001549 Teniposid Teniposide Teniposide (USAN/INN) Teniposide [USAN:BAN:INN] Teniposido Teniposido [INN-Spanish] Teniposidum Teniposidum [INN-Latin] Téniposide UNII-957E6438QA VM 26 VM-26 Vee M-26 Veham-Sandoz Vehem Vumon Vumon (TN) Vumon, VM-26, Vehem, NSC 122819, Teniposide teniposide |
| | 36 | | Bupropion | approved | Phase 4 | 308 | 34841-39-9 | 444 | ( -)-2-(tert-Butylamino)-3'-chloropropiophenone ( -)-2-(tert-Butylamino)-3'-chlorpropiophenon (+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone (+-)-Bupropion .alpha.-(tert-Butylamino)-m-chloropropiophenone 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one 2-(Tert-Butylamino)-3'-chloropropiophenone 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one 34841-36-6 (hydrochloride) 34841-39-9 34911-55-2 AB00053756 AC-197 AC1L198Y AMFEBUTAMONE HCl Amfebutamon Amfebutamona Amfebutamona [INN-Spanish] Amfebutamone Amfebutamonum Amfebutamonum [INN-Latin] Aplenzin BPBio1_000042 BRD-A05186015-003-05-7 BRN 2101062 BSPBio_000038 BSPBio_002247 Budeprion Buproban Bupropion Bupropion (INN) Bupropion (Old RN) Bupropion (USAN) Bupropion Hcl Bupropion Hydrochloride Bupropion SR Bupropion [INN:BAN] Bupropion hydrocloride C06860 CHEBI:3219 CHEMBL894 CID444 CPD000472526 D07591 DB01156 | DivK1c_007050 Elont HMS2051G10 HMS2089G14 Jsp006301 KBio1_001994 KBio2_002143 KBio2_004711 KBio2_007279 KBio3_001467 KBioGR_001168 KBioSS_002143 L000725 LS-122817 Lopac0_000166 MLS001424015 MolPort-003-845-432 NCGC00015122-06 NCGC00089751-02 NCI60_002714 NSC315851 Prestwick0_000249 Prestwick1_000249 Prestwick2_000249 Prestwick3_000249 SAM001246699 SMR000472526 SPBio_001817 SPBio_002257 SpecPlus_000954 Spectrum2_001659 Spectrum3_000644 Spectrum4_000614 Spectrum5_001406 Spectrum_001663 TL8002604 UNII-01ZG3TPX31 Wellbatrin Wellbutrin Wellbutrin SR Wellbutrin XL Wellbutrin Xl Zyban alpha-(tert-butylamino)-m-chloropropiophenone amfebutamonum bupropion | |
| | 37 | | Varenicline | approved, investigational | Phase 4 | 255 | 249296-44-4 | 5310966 | 249296-44-4 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino(2,3-h)(3)benzazepine 7,8,9,10-tetrahydro-6h-6,10-methanoazepino[4,5-g]quinoxaline AC1L55H0 AC1Q4W6H AKOS005145561 AR-1H2911 CHEBI:430452 CHEMBL1396 CID170361 CP 526555 | CP-526,555 Champix Chantix D08669 HSDB 7591 I14-1963 LS-187375 UNII-W6HS99O8ZO Varenicline Varenicline (INN) Varenicline tartrate varenicline | |
| | 38 | | Nicotine | approved | Phase 4 | 973 | 54-11-5 | 942, 89594 | (− (+)-Nicotine (+-)-3-(1-Methyl-2-pyrrolidinyl)pyridine (+-)-Nicotine (-)-3-(1-Methyl-2-pyrrolidyl)pyridine (-)-3-(N-Methylpyrrolidino)pyridine (-)-Nicotine (-)-Nicotine solution (2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine (R)-3-(1-Methyl-2-pyrrolidinyl)pyridine (R,S)-Nicotine (R,S)-nicotine (RS)-nicotine (S)-(-)-NICOTINE, 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE (S)-(-)-Nicotine (S)-3-(1-methylpyrrolidin-2-yl)pyridine (S)-3-(N-methylpyrrolidin-2-yl)pyridine (S)-Nicotine (±)-nicotine )-1-Methyl-2-(3-pyridyl)pyrrolidine )-Nicotine )-Nicotine solution 1-Methyl-2-(3-pyridal)-Pyrrolidine 1-Methyl-2-(3-pyridal)-pyrrolidene 1-Methyl-2-(3-pyridiyl)pyrrolidine 1-Methyl-2-(3-pyridyl)pyrrolidine 1uw6 2'-beta-H-Nicotine 3-(1-Methyl-2-pyrollidinyl)pyridine 3-(1-Methyl-2-pyrrolidinyl)-Pyridine 3-(1-Methyl-2-pyrrolidinyl)pyridine 3-(1-Methylpyrrolidin-2-yl)pyridine 3-(2-(N-methylpyrrolidinyl))pyridine 3-(N-Methylpyrollidino)pyridine 3-(N-Methylpyrrolidino)pyridine 3-N-Methylpyrrolidine 3-[(2S)-1-methylpyrrolidin-2-yl]pyridine 36733_FLUKA 36733_RIEDEL 434F7990-3240-4A43-ACEC-E6CC1E495FA0 46343_FLUKA 46343_RIEDEL 54-11-5 AC1L3I79 AC1Q3ZOC AI3-03424 American Fare Nicotine Transdermal System BB_NC-0777 BIDD:GT0599 BRD-K05395900-322-02-1 Black Leaf Black Leaf 40 C00745 CCRIS 1637 CHEBI:17688 CHEMBL3 CID89594 CPD000059074 Campbell's Nico-Soap Careone Nicotine Transdermal System Step 1 Careone Nicotine Transdermal System Step 2 Careone Nicotine Transdermal System Step 3 Caswell No. 597 Commit D-Nicotine D03365 DL-tetrahydronicotyrine Destruxol Destruxol Orchid Spray EINECS 200-193-3 ENT 3,424 EPA Pesticide Chemical Code 056702 Emo-Nik Equaline Nicotine Transdermal System STEP 1 Exchange Select Nicotine Transdermal System STEP 3 Flux Maag Fumeto bac Fumetobac HSDB 1107 Habitrol Habitrol (TN) Habitrol Patch Nicotine Transdermal System, Step 1 Habitrol Patch Nicotine Transdermal System, Step 2 Habitrol Patch Nicotine Transdermal System, Step 3 Healthmart Nicotine Transdermal System STEP 1 Healthmart Nicotine Transdermal System STEP 2 Healthmart Nicotine Transdermal System STEP 3 Kroger Nicotine Transdermal System STEP 1 Kroger Nicotine Transdermal System STEP 2 Kroger Nicotine Transdermal System STEP 3 L(-)-nicotine L-3-(1-Methyl-2-pyrrolidyl)pyridine L-Nicotine LS-202 Leader Nicotine Leader Nicotine Transdermal System STEP 1 Leader Nicotine Transdermal System STEP 2 Leader Nicotine Transdermal System STEP 3 MLS001055457 | MLS001335905 Mach-Nic Meijer Nicotine Transdermal System STEP 2 Meijer Nicotine Transdermal System Step 1 Meijer Nicotine Transdermal System Step 3 Methyl-2-pyrrolidinyl)pyridine Micotine MolPort-000-744-731 N3876_SIGMA N5511_FLUKA N5511_SIGMA NCGC00090693-01 NCGC00090693-02 NCGC00090693-03 NCGC00090693-04 NCGC00090693-05 NCGC00090693-06 NCGC00090693-07 NCT NICOTINE AND SALTS NSC 5065 NSC97238 Niagara P.A. Dust Nic-Sal Nico-Dust Nico-Fume Nicocide Nicoderm Nicoderm CQ Nicoderm Cq Nicoderm Patch Nicorette Nicorette Plus Nicotin Nicotina Nicotina [Italian] Nicotine Nicotine (USP) Nicotine (compounds related to) Nicotine Alkaloid Nicotine Patch Nicotine Polacrilex Nicotine TRANSDERMAL SYSTEM Nicotine Transdermal System PATCH KIT Nicotine Transdermal System STEP 1 Nicotine Transdermal System STEP 2 Nicotine Transdermal System STEP 3 Nicotine Transdermal System Step 1 Nicotine Transdermal System Step 2 Nicotine Transdermal System Step 3 Nicotine [BSI:ISO] Nicotine [UN1654] Nicotine [UN1654] [Poison] Nicotine [USAN] Nicotine transdermal system Nicotrol Nicotrol (professional Sample) Nicotrol Inhaler Nicotrol Ns Nictoine patch Nikotin Nikotin [German] Nikotyna Nikotyna [Polish] Ortho N-4 Dust Ortho N-5 Dust PDSP1_000113 PDSP1_000465 PDSP2_000463 PDSP2_000555 Prostep R)-(+)-Nicotine RCRA waste no. P075 RCRA waste number P075 Rite Aid Nicotine Transdermal System Step 1 Rite Aid Nicotine Transdermal System Step 2 Rite Aid Nicotine Transdermal System Step 3 SAM002564224 SDCCGMLS-0066911.P001 SMR000059074 Safeway Nicotine Transdermal System STEP 1 Safeway Nicotine Transdermal System STEP 2 Safeway Nicotine Transdermal System STEP 3 Smart Sense Nicotine Sunmark Nicotine Sunmark Nicotine Transdermal System STEP 1 Sunmark Nicotine Transdermal System STEP 2 Sunmark Nicotine Transdermal System STEP 3 Tendust Transdermal Nicotine UN1654 a -N-Methylpyrrolidine a-N-Methylpyrrolidine alpha-N-Methylpyrrolidine beta-Pyridyl-alpha-N-methyl pyrrolidine beta-Pyridyl-alpha-N-methylpyrrolidine bmse000105 delta-Nicotine nicotine nicotine replacement patch | |
| | 39 | | Doxycycline | approved, investigational | Phase 4 | 219 | 564-25-0 | 54671203, 5281011 | (2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione (4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide 10597-92-9 17086-28-1 (mono-hydrate) 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS) 24390-14-5 41411-66-9 (6-epimer, mono-hydrochloride) 5-Hydroxy-alpha-6-deoxytetracycline 564-25-0 6-Deoxyoxytetracycline 6-Deoxytetracycline 6-alpha-Deoxy-5-oxytetracycline 6-alpha-deoxy-5-oxytetracycline 69935-17-7 (mono-hydrochloride, di-hydrate) 6alpha-Deoxy-5-oxytetracycline 6α-deoxy-5-oxytetracycline 7164-70-7 7264-10-0 94088-85-4 (calcium salt (1:2)) AB08 (*Fosfatex) AC1NQXW7 AC1NS4CW AC1NUYS8 AC1O8PYM Adoxa Alodox Alti-Doxycycline Apo-Doxy Atridox Azudoxat BCBcMAP01_000024 BIDD:GT0146 BMY-28689 BPBio1_000951 BSPBio_000863 BSPBio_001936 BU-3839T C06973 CHEBI:50845 CHEMBL1433 CID5281011 CID5353597 CID5463943 CID6713981 CPD001550033 D07876 DB00254 DMSC (*Fosfatex) DOXCYCLINE ANHYDROUS DOXY DOXYCYCLINE CALCIUM DOXYCYCLINE MONOHYDRATE Deoxymykoin DivK1c_000345 Doryx Dossiciclina Dossiciclina [DCIT] Doxcycline anhydrous Doxiciclina Doxiciclina [INN-Spanish] Doxiciclina [Italian] Doxitard Doxivetin Doxy 100 Doxy-Caps Doxy-Puren Doxy-Tabs Doxycen Doxychel Doxychel (TN) Doxycin Doxycyclin Doxycycline Doxycycline (200mg/day) or Placebo Doxycycline (INN) | Doxycycline (TN) Doxycycline (anhydrous) Doxycycline (internal use) Doxycycline Hyclate Doxycycline Monohydrate Doxycycline anhydrous Doxycycline hyclate Doxycycline hydrochloride Doxycycline-Chinoin Doxycyclinum Doxycyclinum [INN-Latin] Doxysol Doxytec Doxytetracycline EINECS 209-271-1 GS-3065 (*monohydrate) HMS2090E06 HSDB 3071 Hydramycin IDI1_000345 Investin Jenacyclin KBio1_000345 KBio2_001287 KBio2_003855 KBio2_006423 KBio3_001156 KBioGR_001133 KBioSS_001287 LS-187766 LS-93868 Liviatin Lopac0_000405 MolPort-002-507-423 Monodox Monodox (*monohydrate) Morgidox NCGC00161602-01 NCGC00161602-03 NCGC00161602-04 NCGC00167961-01 NCGC00179395-01 NINDS_000345 NSC633557 Novo-Doxylin Nu-Doxycycline Ocudox Oracea Prestwick0_000852 Prestwick1_000852 Prestwick2_000852 Prestwick3_000852 Ronaxan SAM002589932 SMP1_000107 SPBio_000246 SPBio_002784 STOCK1N-34341 Spanor Spectrum2_000143 Spectrum3_000408 Spectrum4_000527 Spectrum5_000947 Spectrum_000807 Supracyclin UNII-334895S862 UPCMLD-DP021 UPCMLD-DP021:001 Vibra-tabs Vibramycin Vibramycin (*monohydrate) Vibramycin Monohydrate Vibramycin Novum Vibramycine Vibravenos Vivox (*Hyclate) alpha-6-Deoxy-5-hydroxytetracycline alpha-6-Deoxyoxytetracycline alpha-Doxycycline doxycycline | |
| | 40 | | Folic Acid | approved, nutraceutical | Phase 4, Phase 3, Phase 2, Phase 1 | 2924 | 59-30-3 | 6037 | (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid 01769_FLUKA 2d0k 33609-88-0 36653-55-1 (mono-potassium salt) 59-30-3 6484-89-5 (mono-hydrochloride salt) AC-11682 AC1L1LNX AI3-26387 AKOS000503224 ARONIS014410 Acfol (Spain) Acide folique Acide folique [INN-French] Acido folico Acido folico [INN-Spanish] Acidum folicum Acidum folicum [INN-Latin] Acifolic Antianemia factor Apo-Folic BIDD:ER0563 BIDD:GT0641 BIF0608 BPBio1_000654 BSPBio_000594 BSPBio_002338 C00504 C20H20N6O6 CAS-59-30-3 CCRIS 666 CHEBI:27470 CHEMBL1622 CID6037 CPD000471860 Cytofol D00070 DB00158 DivK1c_000494 Dosfolat B activ EINECS 200-419-0 F0043 F7876_SIAL F7876_SIGMA F8758_SIGMA F8798_SIAL F8890_SIGMA FOL Facid Factor U Folacid Folacin Folaemin Folaemin [Netherlands] Folan Folasic (Australia) Folate Folbal Folcidin Folcidin (VAN) Folcysteine Foldine Foldine [France] Folettes Foliamin Folic Folic Acid Folic acid Folic acid (JP15/USP/INN) Folic acid (TN) Folic acid [BAN:INN:JAN] Folic acid [INN:BAN:JAN] Folic acid dihydrate Folicet Folicet (TN) Folico Folico (Italy) Folina Folina (Italy) Folipac | Folsaeure Folsan Folsaure Folsav Folvite Folvron Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L HMS1921D20 HMS2092N17 HMS501I16 HSDB 2002 IDI1_000494 InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s Incafolic KBio1_000494 KBio2_001861 KBio2_004429 KBio2_006997 KBio3_001558 KBioGR_002222 KBioSS_001861 Kyselina listova Kyselina listova [Czech] LS-2157 Liver Lactobacillus casei factor MLS001304016 MLS001335861 Millafol Mission prenatal Mittafol MolPort-004-285-551 N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid N-Pteroyl-L-glutamic acid N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid NCGC00016265-01 NCGC00142391-01 NINDS_000494 NSC 3073 Nifolin Nifolin [Denmark] Novofolacid Novofolacid [Canada] PGA PGA (VAN) Prestwick3_000627 Prestwick_230 PteGlu Pteroyl-L-glutamate Pteroyl-L-glutamic acid Pteroyl-L-monoglutamate Pteroyl-L-monoglutamic acid Pteroylglutamate Pteroylglutamic acid Pteroylmonoglutamate Pteroylmonoglutamic acid SAM002264616 SDCCGMLS-0066738.P001 SMP2_000137 SMR000471860 SPBio_001357 SPECTRUM1502020 Serum Folate Level Spectrum2_001459 Spectrum3_000749 Spectrum4_001751 Spectrum5_000602 Spectrum_001381 UNII-935E97BOY8 Usaf cb-13 Vitamin B11 Vitamin B9 Vitamin Bc Vitamin Be Vitamin M bmse000299 folic acid nchembio.108-comp10 |
| | 41 | | substance P | investigational | Phase 4, Phase 2, Phase 1, Phase 0 | 217 | 33507-63-0 | 36511, 44359816 | Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
| | 42 | | butyric acid | experimental | Phase 4, Phase 3, Phase 2, Phase 1 | 292 | 107-92-6 | 264 | 1-Butanoate 1-Butanoic acid 1-Butyrate 1-Butyric acid 1-Propanecarboxylate 1-Propanecarboxylic acid Butanate Butanic acid Butanoate Butanoic acid Buttersaeure Butyrate | Butyric acid Ethylacetate Ethylacetic acid Honey robber Kyselina maselna N-Butanoate N-Butanoic acid N-Butyrate N-Butyric acid Propanecarboxylate Propanecarboxylic acid Propylformate Propylformic acid | |
| | 43 | | Antimitotic Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 4296 | | | | 44 | | Cortisol succinate | | Phase 4, Phase 3, Phase 2, Phase 1 | 583 | | | | 45 | | Anti-Inflammatory Agents | | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 8478 | | | | 46 | | Fludarabine phosphate | | Phase 4, Phase 3, Phase 2, Phase 1 | 1059 | | 30751 | | 47 | | Antiviral Agents | | Phase 4, Phase 3, Phase 2, Phase 1 | 8071 | | | | 48 | | Serotonin Antagonists | | Phase 4, Phase 3, Phase 2, Phase 1, Phase 0 | 1175 | | | | 49 | | Antibiotics, Antitubercular | | Phase 4, Phase 3, Phase 2, Phase 1 | 5971 | | | | 50 | | Vitamin B Complex | | Phase 4, Phase 3, Phase 2, Phase 1 | 2847 | | |
Interventional clinical trials: (show top 50)
(show all 445)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | An Observational Study of Lymphoma in Patients With Rheumatoid Arthritis or Crohn's Disease. | Completed | NCT00440817 | Phase 4 | | 2 | PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC Transplantation | Completed | NCT00352703 | Phase 4 | | 3 | AMENO-2: Aprepitant Plus Palonosetron Versus Granisetron in the Prevention of Nausea and the Emesis Induced by Chemotherapy in Patients Treated With Haematopoietic Progenitors | Completed | NCT00415103 | Phase 4 | | 4 | Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia | Completed | NCT00411541 | Phase 4 | | 5 | Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | Recruiting | NCT00274885 | Phase 4 | | 6 | Treatment of Natural Killer/T Cell Lymphoma-I/II | Recruiting | NCT01501136 | Phase 4 | | 7 | Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ | Recruiting | NCT01501149 | Phase 4 | | 8 | Surgery Alone, Surgery With Cyclophosphamide, Vinblastine, and Prednisolone (CVP), or CVP Alone in Treating Young Patients With Stage IA or Stage IIA Nodular Lymphocyte-Predominant Hodgkin Lymphoma | Recruiting | NCT01088750 | Phase 4 | | 9 | A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) | Recruiting | NCT01804166 | Phase 4 | | 10 | Integrating Tobacco Treatment Into Cancer Care: A Randomized Controlled Comparative Effectiveness Trial | Recruiting | NCT01871506 | Phase 4 | | 11 | Rituximab (RTX) Therapy in Patients With Active TAO | Recruiting | NCT02378298 | Phase 4 | | 12 | Thiopurine Induced Pancreatitis in IBD Patients | Recruiting | NCT02281799 | Phase 4 | | 13 | Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS | Recruiting | NCT01540812 | Phase 4 | | 14 | The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia | Recruiting | NCT00846703 | Phase 4 | | 15 | Treatment of High Risk Adult Acute Lymphoblastic Leukemia | Active, not recruiting | NCT00853008 | Phase 4 | | 16 | Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) | Not yet recruiting | NCT02347878 | Phase 4 | | 17 | A Study Evaluating the Efficacy and Safety of Aprepitant in Autologous Hematopoietic Stem Cell Transplantation | Not yet recruiting | NCT02576327 | Phase 4 | | 18 | High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection | Not yet recruiting | NCT02553083 | Phase 4 | | 19 | Low-dose Chemotherapy Combine With Tyrosine Kinase Inhibitor to Treat ph+ Acute Lymphoblastic Leukemia Patients | Not yet recruiting | NCT02690922 | Phase 4 | | 20 | Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome | Terminated | NCT01625455 | Phase 4 | | 21 | Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain | Completed | NCT00538850 | Phase 3 | | 22 | R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma | Completed | NCT00137995 | Phase 3 | | 23 | Combination Chemotherapy in Treating Patients With Lymphoma | Completed | NCT00002835 | Phase 3 | | 24 | Ondansetron With or Without Dexamethasone to Prevent Vomiting in Patients Receiving Radiation Therapy to the Upper Abdomen | Completed | NCT00016380 | Phase 3 | | 25 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma | Completed | NCT00003215 | Phase 3 | | 26 | Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia | Completed | NCT00005977 | Phase 3 | | 27 | Combination Chemotherapy in Treating Patients With Intermediate-Grade or Immunoblastic Non-Hodgkin's Lymphoma | Completed | NCT00002565 | Phase 3 | | 28 | A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With Bortezomib | Completed | NCT01324596 | Phase 3 | | 29 | Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma | Completed | NCT00003187 | Phase 2, Phase 3 | | 30 | Effect of Zoledronic Acid on Chemotherapy Induced Bone Loss | Completed | NCT00352846 | Phase 3 | | 31 | Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia | Completed | NCT00002700 | Phase 3 | | 32 | Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment | Completed | NCT00006348 | Phase 3 | | 33 | Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer | Completed | NCT00002742 | Phase 3 | | 34 | Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET | Completed | NCT00583323 | Phase 3 | | 35 | Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials | Completed | NCT00357903 | Phase 3 | | 36 | Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012 | Completed | NCT00356590 | Phase 3 | | 37 | Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer | Completed | NCT00123760 | Phase 2, Phase 3 | | 38 | Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease | Completed | NCT00195715 | Phase 3 | | 39 | Rituximab in Active Ulcerative Colitis | Completed | NCT00261118 | Phase 2, Phase 3 | | 40 | Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | Completed | NCT00967057 | Phase 3 | | 41 | Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease | Completed | NCT00929695 | Phase 3 | | 42 | Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia | Completed | NCT00720109 | Phase 2, Phase 3 | | 43 | Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia | Completed | NCT00613457 | Phase 3 | | 44 | A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors | Completed | NCT00186901 | Phase 3 | | 45 | Treatment of Acute Lymphoblastic Leukemia in Children | Completed | NCT00165178 | Phase 3 | | 46 | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia | Completed | NCT00005596 | Phase 3 | | 47 | Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia | Completed | NCT00005585 | Phase 3 | | 48 | Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia | Completed | NCT00002816 | Phase 3 | | 49 | Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma | Recruiting | NCT00678327 | Phase 3 | | 50 | Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma | Recruiting | NCT00920153 | Phase 3 |
|
